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I. INTRODUCTION 
Prior to the discovery of the genetic background of craniosynostosis, 
its classification was purely based on clinical features. This 
classification system did however have its pitfalls which became more 
obvious after comparing it with the detected genetic mutations. 
Because this classification has been the basis for clinical practice for 
years and still is applied world wide, this chapter will begin by giving 
a historical and clinical view on craniosynostosis before discussing the 
genetic aspects. 
1.1. Historical and clinical perspectives on craniosynostosis 
Definition, classification, and incidence 
Craniosynostosis is generally defined as the premature (pre- or 
postnatally) closure of one or more cranial suture(s). This condition 
can arise primarily as a congenital malformation, and secondary to 
certain metabolic disorders (e.g., hyperthyroidism, rickets, and 
mucopolysaccharidoses), hematological disorders (e.g., thalassemia, 
sickle cell anemia, and polycythemia vera), holoprosencephaly, and 
microcephaly, or have iatrogenic origin such as following ventricular 
shunting. The focus ofthis thesis is on congenital craniosynostosis. 
Figure la depicts the cranial sutures. The sutures are the sites at which 
the skull can expand to accommodate itself to the enlarging brain. 
Growth takes place in the direction perpendicular to the suture. For 
example, the coronal sutures allow the skull to grow in the 
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anteroposterior direction, while the sagittal sutnre offers the potential 
to expand in the bilateral direction. Most volume expansion of the 
skull occurs in utero and within the fIrst two years of life, although 
most sutures do not ossify before adulthood. OssifIcation of the 
coronal suture, for instance, starts at about 24 years of age (Kokich, 
1986). 
metopic suture 
anterior fontanelle 
coronal suture --II" .~~¥ 
sagittal suture --1fI{----; 
posterior fontanelle ~~_ 
lan~bdoid suture 
Figure I a. The cranial sutnres as seen from a birds' eye view. 
Premature closure of a sutnre will cause the cessation of growth 
within the associated direction. Subsequently, compensatory growth is 
observed in the remaining sutnres. If the coronal sutures were to be 
synostotic, insuffIcient growth in the anteroposterior direction would 
occur and additional growth takes place at the non-affected sutures, 
thus resulting in a broad skull with reduced anteroposterior 
dimensions. Figure I b illustrates the associated skull confIgurations 
for each synostotic suture and the commonly applied nomenclatnre. 
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Although the lambdoid sutures can be synostotic too, this is a very 
rare condition (Huang et ai., 1996). Most patients presenting with a 
flattened occiput do not suffer from craniosynostosis. This 
dysmorphology appears to be induced by the commonly advised 
supine position for neonates to sleep in, and seems to reflect a 
molding effect rather than an intrinsic abnormality of the lambdoid 
suture. The most severe skull deformity in syndromic craniosynostosis 
is the cloverleaf skull, referring to the image seen on X-ray (fig. lc). 
This is often a life-threatening condition due to respiratory failure. In 
most cases, all cranial suture have fused. 
F'klgi1x:~pl:rnly !)X:[pwlll 
plagi~balr 
Figure lb. The associated skull configurations resulting from specific 
synostotic sutures and the commonly applied nomenclature. 
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Figure 1c. X-ray of a patient with a cloverleaf skull. In anteroposterior 
direction the skull has the shape of the three leaves of a clover, formed 
by the bulging temporal bones bilaterally. The lateral view shows 
impressiones digitatae, suggestive of increased intracranial pressure. 
One of the major distinctions that is made in craniosynostosis is 
whether or not this anomaly arises solitarily, i.e. isolated, or combined 
with other congenital malformations, constituting a craniosynostosis 
syndrome. Sagittal suture synostosis or scaphocephaly represents the 
most common isolated form of craniosynostosis with a male: female 
ratio of3.5:1, showing the male predominance (Lajeunie et aI., 1996). 
Very rarely, familial cases with 2 or more affected scaphocephalic 
members occur (Hunter and Rudd, 1976; Berant and Berant, 1973; 
Lajeunie et aI., 1996). In 1996, a new designated autosomal dominant 
craniosynostosis syndrome was suggested, being the Philadelphia 
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type, which is characterized by sagittal synostosis and soft tissue 
syndactyly of the fingers and toes (Robin et ai., 1996). 
Isolated synostosis of either the metopic suture, i.e., trigonocephaly, 
or one or both coronal sutures, i.e., plagiocephaly or brachycephaly 
respectively, does occur but one needs to rule out an underlying 
syndrome (chapter 1.2). Analysis of a series of 237 patients with 
trigonocephaly resulted in 184 cases with an isolated synostosis and 
53 cases with a syndromic form (Lajeunie et ai., 1998). Of these 53, 
13 concerned well-delineated syndromes, while the remaining 40 
couldn't be assigned to any of the known syndromes. As with isolated 
sagittal suture synostosis, an increased incidence of twinning (7.8 %, 
both monozygotic and dizygotic) was observed, up to about three 
times higher compared to the normal population (Lajeunie et ai., 
1998). Of the monozygotic twins two were concordant and three were 
disconcordant for synostosis. 
In craniosynostosis syndromes, the coronal sutures are usually 
affected and the most commonly associated malformations involve the 
upper and lower extremities. Limb abnormalities can be as subtle as 
unusually shaped phalangeal bones without any functional impairment 
but can also be as severe as complex syndactyly, involving bone, 
nails, and soft tissue fusion, of all fingers and toes. 
A large number of craniosynostosis syndromes have been depicted 
(Cohen, 1986), with their nomenclature often referring to the authors 
who were first to describe them. Here, a short overview is given of the 
common syndromes. 
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Apert syndrome has the most consistent presentation and was initially 
reported as acrocephalosyndactyly by Apert in 1906. The following 
hallmarks are nearly always present: bilateral coronal sutnre 
synostosis, a wide open gap between the frontal bones instead of the 
frontal sutnre at birth, exorbitism, strabismus, midfacial hypoplasia, 
joint ankylosis, and symmetrical, complex syndactyly of the hands 
and feet (Cohen and Kreiborg, 1993a; Cohen and Kreiborg, 1995). 
Mental retardation is a common finding. 
First described by Crouzon in 1912, the Crouzon syndrome IS 
characterized by craniosynostosis, although not always present at 
birth, in which eventnally all calvarial sutnres can be involved 
(pansynostosis), midfacial hypoplasia, exorbitism, epilepsy, and 
seemingly unaffected limbs. Its diagnosis is mainly founded on the 
absence of overt deformities of the hands and feet. Recently, however, 
subtle radiographic abnormalities like carpal fusion have been found 
in patients with Crouzon syndrome (Anderson et aI., 1997; Murdoch-
Kinch and Ward, 1997). 
Both H. Saethre (1931) and F. Chotzen (1932) have established the 
Saethre-Chotzen syndrome. Typical characteristics are considered to 
be bilateral coronal synostosis, hypertelorism, unilateral or bilateral 
ptosis of the eyelids, low-set hairline, hearing loss, brachydactyly, and 
soft tissue syndactyly. 
R.A. Pfeiffer depicted another type of craniosynostosis III 1964, 
although he referred to this condition as a weak form of Apert 
acrocephalosyndactyly. Clinical presentation of this syndrome 
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involves besides bicoronal synostosis broad and deviated thumbs and 
halluces, and hypertelorism (Cohen, 1993b). 
The description of Jackson-Weiss syndrome was based on one 
extremely large Amish family (Jackson et aI., 1976). This syndrome 
was considered to be different from the classical Pfeiffer syndrome 
because evident thumb abnormalities were lacking. The phenotypic 
presentation ranged from just radiological abnormalities of the feet to 
craniosynostosis, hypertelorism, exorbitism, midface hypoplasia, and 
deviated great toes with deformed proximal phalanges and first 
metatarsals. This was the first report presenting an impressive number 
of patients with at least 88 affected siblings and possibly another 50. 
The autosomal dominant inheritance pattern was clearly outlined in 
this family, showing variable expression. The authors stated that 
individual evaluation of some of these family members could result in 
either the diagnoses Pfeiffer or Crouzon syndrome. Because 
distinction between Jackson-Weiss and these syndromes is so 
difficult, the value of the Jackson-Weiss entity, besides for the original 
family members, is under increasing doubt (Reardon and Winter, 
1995). 
Beare-Stevenson syndrome is much more rare and characterized by 
severe craniosynostosis (mostly a cloverleaf skull), cutis gyrata and 
acanthosis nigricans, digital anomalies, external ear defects, 
anogenital anomalies, skin tags, prominent embilical stump, and early 
death (Beare et aI., 1969; Stevenson et aI., 1978; Hall et aI., 1992). 
In short, classification of syndromic craniosynostosis is mainly based 
on the associated craniofacial features and limb abnormalities, 
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although these are seldom pathognomonic for a certain diagnosis. Due 
to the overlapping features little consistency exists in diagnosing 
patients with a craniosynostosis syndrome, proving the existing 
classification system to be insufficient. The drawbacks of this 
traditional classification system are further discussed in part 2 of this 
chapter. 
Especially since the discovery of genetic mutations 1ll 
craniosynostosis syndromes (chapter 1.2), an increasing number of 
cases originally diagnosed as isolated craniosynostosis had to be 
redefined. Subsequently, mutation carriers who are mildly affected 
were recognized, causing a rise in the incidence number of 
craniosynostosis. The most recent number states a frequency of 1 in 
2,000-2,500 live births for craniosynostosis, including isolated and 
syndromic cases (Lajeunie et aI., 1995a). 
12 
Diagnosis and treatment 
The diagnosis of craniosynostosis is made by the clinical presentation 
of the patients with the characteristic skull deformation indicating 
which suture(s) is (are) affected (fig. Ib). A skull X-ray is used to 
confirm this diagnosis, for which routinely photographs in three 
directions are taken: in anteroposterior direction to visualize the 
frontal and sagittal sutures, the lateral view reveals the coronal 
sutures, and a Tschebull or Towne's X-ray is indicated to asses the 
lambdoid sutures. Open sutures are visible as black lines. In case of a 
synostotic suture, it will be reflected as a white line on the film (fig. 
2), due to the presence of bone at that site. In case of a coronal suture 
synostosis, an additional radiographic sign can be seen, the 
Harlequins' eye. Because of the secondary displacement of the 
sphenoid's lesser wing the orbit is deformed, presenting in a 
characteristic way on the X-ray (fig. 2). 
Besides the malformations of the cranium, face and extremities, 
patients with craniosynostosis can present with numerous other 
congenital malformations. The most common ones are dilated 
ventricles or hydrocephalus with or without increased intracranial 
pressure (Hanieh et aI., 1989), corpus callosum agenesis, Arnold-
ehiari malformation (herniation of the cerebellar tonsils through the 
foramen magnum), mental retardation, epilepsy, strabismus, 
obstructive respiratory problems (Gonsalez et aI., 1997), cleft palate, 
malocclusion, hearing difficulties, skin disorders, and heart 
malformations. 
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Figure 2. X -ray of unilateral coronal suture synostosis seen from a 
frontal and a lateral view. On the frontal view the orbit on the 
synostotic side has an altered shape, referred to as Harlequins' eye, 
due to the displacement of the sphenoid wing (indicated on both sides 
by arrows). From the side, the coronal suture on the affected side is 
visible as a white line (black arrows), while the non-synostotic suture 
is reflected as a black line (white arrows). 
Besides these inborn malformations, patients are also at risk for 
developing secondary abnormalities as a result of the 
craniosynostosis. For example, exorbitism with inadequate eyeball 
protection can cause corneal lesions, with secondary vision loss 
(Buncic, 1991). Likewise, an increased intracranial pressure may 
cause compression of the cerebrum and optic nerves (Renier et a!., 
1982; Gault et a!. 1992; Stavrou et a!., 1997). Because the spectrum of 
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problems of these children is so broad, they require treatment in a 
multidisciplinary craniofacial team. 
The main method of treatment for craniosynostosis remains surgery 
(McCarthy et aI., 1995a; McCarthy et aI., 1995b). Initiated by dr. Paul 
Tessier in the early 60's, the basic principles of operation have stayed 
the same. The aim of surgery is to correct the primary skull 
deformities to prevent the induction of secondary malformations, and 
to normalize the patients' appearance. A variety of surgical methods 
can be applied, depending on the clinical presentation. For instance, 
operative treatment for the scaphocephalic skull focuses on 
broadening of the skull by allowing the parietal bone to bulge 
sideways through certain osteotomies. In most syndrornic cases, 
retrusion of the forehead and shallow orbits are routinely corrected by 
performing a fronto-orbital advancement, in which the frontal bones 
and supraorbital rim are taken out, remodeled and inserted in a more 
anterior and caudal position. The cranial corrections give the calvaria 
its growth in one stage, which is normally offered by the sutures in 
years. For this reason, some overcorrection is applied during the 
procedures, as in time the achieved "growth" will be surpassed. In 
general, these operations are scheduled within the first year of life of 
the patient. 
Other corrections are the Le Fort I, II and III osteotomies, referring to 
the level of osteotomies of the facial skeleton, to advance the maxilla 
and/or midface. These interventions improve occlusion, reduce 
breathing difficulties and normalize the patients' appearance. The 
policy in the craniofacial center of Rotterdam is to postpone these 
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operations until the age of 18 years when growth of the upper and 
lower jaw has taken place. In that way, the intrinsic growth capacity of 
these bones is not further restricted because of the surgical 
intervention. On top of that, a more reliable result can be achieved in 
young adults because the jaws can be brought to their definitive 
position, reducing the risk of having to do this high-risk surgery again. 
A second procedure in scarred tissue is technically much more 
difficult and associated with a higher complication rate. Of course, 
psychosocial problems may make it desirable to perforru the operation 
at an earlier stage. The younger the patient is at the time of surgery, 
the more likely it is that a second operation (LeFort I) later in life is 
required. In the most extended method of reconstruction, the 
monoblock procedure, a fronto-orbital advancement is combined with 
a Le Fort III. This type of surgery is usually only indicated for those 
infants who present with very severe upper airway obstruction and/or 
severe exorbitism. 
The latest development in surgical treatment of craniosynostosis is 
gradual distraction of the facial skeleton according to the principles of 
Ilizarov (McCarthy et aI., 1992). Instead of advancing the facial bones 
in one step during surgery - with the overlying soft tissue restricting 
the obtainable degree of advancement - a distraction device is inserted 
at the sites of the osteotomies. Lengthening of the bones is achieved at 
a rate of I mm a day, until the desired advancement is obtained. In this 
way the soft tissue is stretched too at a limited speed rate, and 
eventually more advancement can be obtained. 
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Literature overview on pathogenesis 
The earliest publications on the underlying cause of craniosynostosis 
described some sort of infection, mostly syphilis (Virchow, 1852). 
Another explanation, persistently appearing in the literature in a 
variety of ways, is that of mechanical constraint. In 1918, Thoma 
stated that the cranial deformity in craniosynostosis is the result of 
intrauterine compression. This theory is still used to explain the higher 
incidence of dizygotic twins with isolated craniosynostosis, compared 
to the normal population (Lajeunie et aI., 1996). Burke et al. (1995) 
stated that normally mechanical forces are necessary to remove 
developing bone microspicles that are bridging the sutures. Synostosis 
would be the result of bony bridges being too strong or fracturing 
forces being too weak, for instance because of reduced fetal activity or 
intrauterine constraint of the head. 
A biomechanical explanation with the defect located at the skull base 
resulting in synostosis has been indicated by Moss (1975). This 
hypothesis suggests that through an unspecified dysostosis of the 
cranial base the location and the tensile forces between the cranial 
base and the neurocranium - transmitted by the dura- are altered, 
resulting in premature fusion of the sutures. Although there has been 
no scientific basis for this theory, it is the one most frequently referred 
in literature. Ozaki et al. (1998) also suggested biomechanical forces 
as component of the pathophysiology of sagittal synostosis. Evidence 
for this theory was supposed to be given by statistical differences of a 
number of measurements on bone biopsies of sagittal sutures obtained 
during surgery. However, at that time one is dealing with the 
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secondary effects of the synostosis that has taken place prenatally 
(chapter 11.2). Therefore, it is no surprise that microscopically an 
alteration in bone architecture arises. Johnson et al. (2000) reported 
three family members with a mutation in the FGFR2 gene, commonly 
found in craniosynostosis (chapter 1.2), of whom only one had a 
unicoronal suture synostosis. The obstetric history of this girl revealed 
a persistent breech presentation with apparent skull compression at the 
time of delivery by Caesarean section. The authors proposed an 
interaction between the genetic mutation and intrauterine constraint, 
leading to craniosynostosis. Other investigations have disputed the 
biomechanical models, such as the following. In a sheep fetus, 
excising the coronal suture and packing this site with bone powder 
through ex utero surgery induced coronal synostosis. After this 
manipulation, skull base deformations arose, suggesting these to be 
secondary to the suture pathology (Stelnicki et al., 1998a). The 
occurrence of these secondary deformities of the skull base could even 
be prevented when the suture was re-opened, further substantiating the 
theory that the primary site of craniosynostosis lies within the suture 
itself(Stelnicki et aI., 1998b). 
In conclusion, no convincing evidence for a mechanical factor 
involved in the initiation of craniosynostosis has yet been given. 
Minchin (1856) and Fridolin (1885) supported the "unituberal 
theory". This theory states that the two fused bones of the skull have 
actually arisen out of one single bone center (i.e., tuber) during skull 
development, instead of separate bone centers. In other words, no 
suture was ever developed. Wyman (1868) proved this theory to be 
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wrong by demonstrating a scaphocephalic skull in which only part of 
the sagittal suture was synostotic, which is incompatible with the 
unituberal hypothesis. Morselli (1875) suggested that scaphocephaly 
could arise because the ossification centers of the parietal bones had 
approached one another. Likewise, Rieping (1919) described how the 
bone centers were displaced toward the synostotic coronal suture and 
appeared to have united into one single ossification center. This 
implies that initially there were separate frontal and parietal bone 
centers. Park and Powers (1920) considered the defective 
development to have arisen in the specialized suture tissue (the 
blastema) with the ossification and bone center displacement going 
wrong secondarily. 
Indeed, a characteristic displacement of the involved bone centers can 
be seen on the calvaria of craniosynostotic patients, as described by 
our group (chapter II.!). Our initial theory stated that the involved 
bone centers had arisen on an abnormal position during skull 
development, resulting in fusion of the two outgrowing bones instead 
of suture formation. However, following the discovery of the 
underlying genetic mutations in craniosynostosis syndromes and a 
study on bone center positions in rabbit embryos suffering from 
craniosynostosis (Dechant et a!., 1999) our ideas have been adjusted. 
We now consider the observed displacement of bone centers to be the 
result of premature bone differentiation within the suture, with 
subsequent suture ossification and bone fusion (chapter 11.2). 
The discovery of the genetic background of craniosynostosis 
syndromes has shed a new light on its pathogenesis and classification. 
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Research on the pathogenesis of craniosynostosis has benefited highly 
from the successes of genetic research. By studying the normal 
expression patterns and functions of the genes involved during skull 
development, a more profound idea on their impact when mutated is 
given. Current knowledge on genes in craniosynostosis, their 
expression and function during skull development and how they 
induce craniosynostosis when mutated are discussed in the following 
sections. 
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1.2. Genetic background of syndromic craniosynostosis 
Genes and craniosynostosis 
The genes first associated with craniosynostosis were the Gli3 gene 
(chromosome 7) causing Greig syndrome (Brueton et a!., 1988) and 
the MSX-I gene (chromosome 5) causing Boston type 
craniosynostosis in a single family (Jabs et a!., 1993). These two 
syndromes, however, are rare forms of craniosynostosis and are for 
that reason left out of the focus of this thesis. 
For most craniosynostosis syndromes an autosomal dominant 
inheritance pattern has been observed but it was not before 1994 that 
the first report on identified gene mutations causing common 
syndromic craniosynostosis came out. It described mutations in the 
gene encoding the fibroblast growth factor receptor 2 (FGFR), located 
on chromosome 10, in patients with Crouzon syndrome (Reardon et 
a!., 1994). Shortly after, additional mutations in FGFR2, FGFRI 
(chromosome 8), FGFR3 (chromosome 4) and TWIST (chromosome 
7) were reported (table I). All the disorders caused by these mutations 
show an autosomal dominant inheritance pattern and thus carriers 
have a 50% change of transmitting the mutation. Homozygosity has 
never been encountered and is perhaps a lethal condition. 
So far, four fibroblast growth factor receptors (FGFRI to 4) are 
known with at least 20 ligands, the fibroblast growth factors (FGFs). 
The amino acid sequences of the FGFRs are highly conserved among 
vertebrate species (Wilkie et a!. 1995a; Twigg et a!., 1998). The FGFs 
and FGFRs have their own distinct pattern of expression during 
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development, although little is known with respect to their expression 
during skull development. Mutations in FGFR4 have never been 
detected in craniosynostosis (Gaudenz et aI., 1998), and since its 
expression pattern during embryogenesis does not include the skeleton 
(Stark et aI., 1991; Iseki et al., 1999) FGFR4 will probably not be 
involved in craniosynostosis. For this reason, aspects on FGFR4 are 
left out ofthis section. 
FGFRs consist of an extracellular part with the FGF binding capacity, 
a hydrophobic transmembrane part and an intracellular tyrosine kinase 
domain (fig. 3). The extracellular domain is made up of three 
immunoglobulin-like domains (IgI, II, and III) of which only the 
second and third is essential for ligand binding. Normally, the IgIII is 
stabilized through intramolecular disulfide bonding. For FGFR2 this 
disulfide bridge is formed between Cys-278 and Cys-342 (Robertson 
et aI., 1998). When the ligand binds in the presence of heparan sulfate 
proteoglycans the receptors dimerize and kinase activation results in 
the intracellular domain. 
Through alternative splicing of the FGFR mRNA transcripts, different 
splice forms of the FGFR are synthesized, thus increasing structural 
diversity and selective responsiveness amongst the receptors (Twigg 
et aI., 1998). Some exons of the gene are coding for a specific domain 
of the receptor. Exon 10 encodes the transmembrane domain while 
exon IlIa encodes a portion of the linker region between the IgII 
domain and the fITst half of the third Ig domain. The second half of the 
IgIII domain is either transcribed by exon IIIb or IIIc. Either of them 
is exclusively expressed in one specific receptor splice form (Miki et 
22 
ai., 1992). For FGFR2, the two resulting splice forms are KGFR 
(keratinocyte growth factor receptor, including IIIb) and BEK 
(bacterially expressed kinase, including IIIc). The two alternative gene 
products are identical except for a 49-amino acid sequence (Reardon 
et ai., 1994), and have their own expression pattern and specificity for 
the ligands. How FGFR2 gene transcription and alternative splicing is 
normally regulated is unknown, let alone what the effect of a mutation 
maybe. 
Figure 3. Schematic structure of FGFR2, consisting of the leader 
sequence (L), three extracellular Ig-like domains (I, II, III), acidic 
domain (A), transmembrane region (TM) , and intracellular tyrosine 
kinase domains (TKI, TK2). Either domain IIIb or domain IIIc is 
present because of alternative splicing (KGFR and BEK form of 
FGFR2, respectively). 
Most genetic mutations in craniosynostosis have been identified in 
exon IIIc of the FGFR2 gene, thus affecting the BEK isoform. 
The TWIST gene contains two exons and encodes a transcription 
factor with a basic helix-loop-helix (bHLH) motif. The HLH motif is 
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important for dimerization, whereas the basic domain is essential for 
binding of the dimer complex to a target DNA-binding sequence. 
Most probably, FGFRs are downstream targets of TWIST (Howard et 
aI., 1997). Shishido et al. (1993) demonstrated the necessity of TWIST 
for expression ofDFRI, a FGFR homologue of Drosophila. 
A striking phenomenon during the discovery of genetic mutations in 
craniosynostosis was the fact that identical mutations (the same 
replacement of one amino acid for the other, on exactly the same 
position) were traced in patients with different clinical diagnoses 
(table 1). In addition, a specific clinically depicted syndrome was 
related to a range of mutations, even within different genes (table I). 
These findings clearly show that the classical classification based on 
phenotype does not cover the genotype. Some aspects of the FGFR 
and TWIST mutations are discussed below. 
FGFRI mutations 
In 1994, Robin et al. linked five families with a craniosynostosis 
syndrome to chromosome 8. Clinically, they were diagnosed as 
having Pfeiffer syndrome. In these linked families a missense 
mutation within exon IIIa of the FGFRI gene was later identified, 
resulting in a Pr0252Arg substitution in the FGFRI protein (Muenke 
et aI., 1994) at the linker stretch between the second and third Ig-like 
domain. Several individuals of a family positive for the Pro252Arg 
mutation did not exhibit the characteristic broad thumbs of Pfeiffer 
syndrome but only the broad halluces (Rutland et aI., 1995). 
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Comparing craniosynostosis patients with the FGFR1 mutation to 
those with a FGFR2 mutation suggested that the FGFR1 mutation 
induces a milder phenotype, both for hand anomalies and degree of 
exorbitism (Robin et aI., 1998a). 
Besides the Pro252Arg, no other mutations in the FGFR1 gene have 
been reported so far. Given the low frequency of reports on this 
Pro252Arg mutation, it seems to be a relatively uncommon mutation 
within the spectrum of FGFR-related craniosynostosis. However, the 
relatively mild presentation caused by this FGFR1 mutation can make 
it more difficult to recognize affected persons, thus contributing to a 
low reported frequency. 
FGFR2 mutations 
Mutation in the FGFR2 gene have been related to the following 
clinical diagnoses: Apert syndrome, Crouzon syndrome, Pfeiffer 
syndrome, Saethre-Chotzen syndrome, Jackson-Weiss syndrome, 
Beare-Stevenson syndrome, and unclassified craniosynostosis (table 
1). Clinically, no distinction could be made between a mutation 
located in the IlIa or IlIc exon (Oldridge et aI., 1995). This finding 
suggests that the FGFR2 BEK (IlIa-IlIc) variant and not the KGFR 
(IlIa-lIIb) generates most influence on craniofacial morphology. 
The effect of the mutations can be explained by assuming that the 
FGFR mutations give rise to a new function, a so called gain of 
function. A distinction can be made in the inducing mechanism: 
(1) Mutations causing increased receptor activity through abnormal 
disulfide bond formation, and 
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(II) Mutations causing structural alterations of the receptors which 
affect their binding kinetics for the FGFs. 
Ad 1. The group of mutations affecting disulfide bond formation is 
further subdivided in (a) cysteine mutations and (b) 
noncysteine mutations. 
a. An example of a cysteine mutation causing increased receptor 
activity is Cys342Tyr, which was shown to promote activation 
of the mutant receptor in the absence of ligand (Neilson and 
Friesel, 1995). The cysteine mutations either create or replace 
a free cysteine residue in the IgIII domain of FGFR2 which 
can form an intermolecular disulfide bond with another 
receptor molecule and thus cause receptor dimerization and 
activation (Neilson and Friesel, 1995; Mangasarian et aI., 
1997). 
b. The noncysteine mutations can not be distinguished clinically 
from the cysteine mutations and it was thus thought that a 
similar activation mechanism had to be the result of these 
mutations. These mutations can be divided in two subgroups. 
One group is centered around Trp290, altering the local 
structure of the normal disulfide bonded cysteines C278 and 
C342, essential for stabilizing the IgIII domain. The other 
group is situated near Thr341 and causes a displacement of 
Cys342, moving it out of bonding range with Cys278 and thus 
making Cys342 available for intermolecular binding instead of 
intramolecular binding (Robertson et aI., 1998). 
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Ad II. The mutations Ser252Trp and Pro253Arg alter the relative 
orientation of the IgII and IgIII domains. This results in a 
reduced dissociation of FGF2 from FGFR2 constructs 
containing either of these two mutations compared to wild-
type, while the association rate was unaffected (Anderson et 
aI., 1998). Dissociation rate from Ser252Trp was slowest, 
matching the more severe craniofacial dysmorphology 
associated with this genotype. The altered dissociation rate 
turned out to be specific for FGF2, while FGFl, FGF4 or 
FGF6 binding kinetics were not altered. This specificity for 
FGF2 could explain why a generalized defect in FGFR2 results 
in tissue-specific abnormalities. 
There remain a number of mutations for which the effect on the 
receptor is unclear. 
Matching the traditional classification of craniosynostosis syndromes 
and the detected genetic mutations was unsuccesful. Patients with an 
identical genetic mutation showed considerable variation in 
phenotype, while a particular clinical craniosynostosis syndrome was 
related to a list of mutations, even within different genes (table 1). 
Clinical diagnosis in syndromic craniosynostosis is made by the 
presence of additional features which are hardly ever pathognomonic 
(Mulvihill, 1995) and which often overlap for the different syndromes. 
The reported clinical diagnosis for a particular patient and thus for the 
detected genetic mutation can therefore be questioned and partially 
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explain why a certain mutation is said to be associated with numerous 
craniosynostosis syndromes. For example, the Ala344Gly mutation, 
detected in the original Jackson-Weiss family, has also been reported 
in Crouzon patients (Gorry et aI., 1995). An important feature of this 
mutation is extreme intrafamilial variability of phenotype in which 
features of all other craniosynostosis syndromes are represented. 
On the other hand, some consistencies between the clinical and 
genetic classification exists. For instance, the consistent presentation 
of Apert syndrome is reflected in the genetic pattern (Wilkie et aI., 
1995b), with about 99% (190/192 patients, Anderson et aI., 1998) of 
the patients having either a Ser252Trp (64%) or Pro253Arg mutation 
(36%) (Slaney et aI., 1996). Even the subtle subdivisions that can be 
made within the group of Apert patients appear to be mirrored in the 
mutation, with. the Pro253Arg mutation associated with more severe 
complex syndactyly of the hands and feet compared to the Ser252Trp 
mutation (Slaney et aI., 1996; Lajeunie et aI., 1999b; Von Gernet et 
al.,2000). 
Nearly all cases of Apert syndrome are due to de novo mutations and 
a clear correlation with increased paternal age was demonstrated in 
1987 (Risch et al.). The origin of these de novo mutations has been 
shown to be exclusively paternal (Moloney et aI., 1996). Although the 
recurrence risk for these elderly fathers is assumed to be low, Oldridge 
et al. (1997) have speculated that several of the FGFR mutations could 
have a selective advantage during spermatogenesis, in which the 
FGF2/FGFR signalling pathway appears to play an important role 
(Van Dissel-Emiliani et aI., 1996). In rare cases a germ-line 
28 
mosaicism could underlie the transmission of the mutation and only 
for these fathers the recurrence risk is not as extremely low as for the 
others (Moloney et aI., 1996; Plomp et aI., 1998). Recently, II 
different de novo mutations in FGFR2 causing Crouzon syndrome and 
Pfeiffer syndrome were also found to be of paternal origin (Glaser et 
aI., 2000). 
In order to reach a new clinically relevant classification based upon 
the genetic mutation analysis, all possible clinical presentations of 
each mutation should be collected. Because nearly all patients with a 
craniosynostotic syndrome are currently tested, the number of 
detected mutations is increasing. Perhaps this results in recognising 
additional phenotypical consistencies of other mutations. Of course, 
the most pronounced manifestations will be distinghuised first, as has 
been observed for the Ser351Cys mutation (chapter IV.!; Gripp et aI., 
1998a). Further consideration on this subject are given in the general 
discussion (chapter V). 
FGFR3 mutations 
Genetic alterations within the FGFR3 gene were already known to be 
associated with the skeletal disorders achondroplasia, 
hypochondroplasia, and thanatophoric dysplasia (reviewed by Muenke 
and Schell 1995; Webster and Donoghue, 1997; Gorlin, 1997). 
The first two papers (Meyers et aI., 1995, Wilkes et aI., 1996) on 
FGFR3 mutation-related craniosynostosis concerned patients with 
Crouzon syndrome and acanthosis nigricans. The patients were found 
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to carry the Ala391Glu transmembrane domain mutation. An 
intriguing observation is the fact that acanthosis nigricans in Crouzon 
and Beare-Stevenson syndromes is linked to both FGFR2 and FGFR3 
gene mutations, suggesting that FGFR2 and FGFR3 interact or have 
redundant functions (Przylepa et aI., 1996). 
Somewhat later, another site of amino acid substitution within the 
FGFR3 gene was traced (Bellus et aI., 1996), being the Pr0250Arg in 
the extracellular domain. By presenting 61 persons from 20 unrelated 
families with this point mutation this craniosynostosis syndrome was 
delineated by Muenke et ai. (1997). It is because of their paper that the 
FGFR3 mutation Pr0250Arg related craniosynostosis is now often 
referred to as Muenke syndrome. The majority of the described 
patients were initially diagnosed as Pfeiffer syndrome (Robin et aI., 
1994), while others were referred to as having Crouzon syndrome, 
Saethre-Chotzen syndrome, craniosynostosis-brachydactyly syndrome 
(Glass et aI., 1994) or non-syndromic craniosynostosis. From the 
study by Muenke et ai. (1997) it became clear that carriers of the 
Pro250Arg mutation could present with an extremely variable 
phenotype, which is described in detail in chapter IV.2. The variable 
phenotype was observed both between families as well as within one 
family. Hollway et ai. (1998) recommended to test all patients with 
uni - or bilateral coronal suture synostosis that lack the classical 
presentation of other craniosynostosis syndromes for this mutation 
first. This screening should also include the at risk relatives of 
confirmed cases, given the mild manifestations or even completely 
normal phenotype that can occur with this mutation (Gripp et aI., 
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1998b; Robin et ai., 1998b). The effect of the Pro250Arg mutation 
seems to result in a more severe phenotype in females than in males 
(Lajeunie et ai., 1 999a). This sex related presentation points to the 
possible implication of modifying genes in this syndrome. The 
Pro250Arg mutation in the FGFR3 gene now appears to be the most 
common one causing craniosynostosis. Based upon a study done by 
Moloney et ai. (1997) the mutation rate at this nucleotide was even 
shown to be one of the highest described in the human genome. 
The Ala391Glu substitution in FGFR3 has been reported to activate 
receptor functioning presumably through stabilization of dimers due to 
hydrogen bonding (Webster and Donoghue, 1997). The Pr0250Arg 
mutation in FGFR3 gene is considered to be equivalent to the 
Pr0253Arg mutation in FGFR2, which results in a ligand-dependent 
constitutively activated receptor (Anderson et ai., 1998). 
In summary, all mutations in the FGFR genes appear to cause 
increased signalling of the receptor, through different mechanisms. 
The fact that phenotypically related craniosynostosis syndromes can 
arise from mutations in three different FGFR genes suggests an 
overlap in their functioning in skull development (Webster and 
Donoghue, 1997). Indeed, FGFR1, 2 and 3 have been located within 
the sutural territory during skull development (Iseki et ai., 1999; this 
chapter). 
TWIST mutations 
The locus for Saethre-Chotzen syndrome was initially mapped to the 
short arm of chromosome 7 (Brueton et ai., 1992). Howard et ai. 
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(1997) and El Ghouzzi et al. (1997a) found mutations in and near the 
TWIST gene, with more papers and additional mutations to follow 
(table I). 
The TWIST mutations listed in table 1 are of vanous types. 
Frameshift mutations are mutations that arise by deletions or 
insertions that are not a multiple of 3 base pairs. They change the 
frame in which triplets are translated into protein. A missense 
mutation is a single DNA base change that leads to a codon that 
specifies a different amino acid. A nonsense or stop mutation is any 
change in DNA that causes a (termination) codon to replace a codon 
representing an amino acid. 
Besides intragenic mutations, a substantial number of mutations 
concern translocations and/or deletions. A practical problem 
associated with genetic analysis for TWIST mutations is the fact that 
cytogenetically invisible deletions of the gene may account for 
Saethre-Chotzen phenotype (Johnson et aI., 1998). In these cases, 
screening the coding region will reveal no abnormalities with only the 
wild type copy being present. This could at least partially explain the 
limited number of detected TWIST mutations in Saethre-Chotzen 
syndrome. Johnson et al. (1998) tested this pitfall and found 
microdeletions in 4 patients, of which only one would have been 
suspected based on conventional cytogenetic analysis. By applying 
additional techniques, the sensitivity of recognizing TWIST deletions 
approached 100% (Zackai and Stolle, 1998). 
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El Ghouzzi et al. (2000) demonstrated that TWIST mutations cause 
loss of TWIST protein function through at least two distinct 
mechanisms: 
1. nonsense mutations which result in the synthesis of truncated, 
unstable proteins that are rapidly degraded. 
2. an abnormal cytoplasmic localization of the TWIST mutant protein 
which may account for its inability to bind DNA. 
This would imply that in normal development TWIST acts as a down-
regulator of FGFR transcription, as has been suggested for the 
Drosophia (Shishido et aI., 1993). 
The fact that clinically one cannot easily distinguish between a 
TWIST or FGFR mediated craniosynostosis also points out the 
likelihood that these genes interact and that their mutations probably 
result in a similar disturbance of biological processes. paznekas et al. 
(1998) detected all sorts of TWIST mutations in 17 of 37 patients 
suspected for Saethre-Chotzen syndrome (46%). Besides those in the 
TWIST gene, mutations were also found in the FGFR2 gene (1 
patient) and in the FGFR3 gene (7 patients), while no mutations were 
detected in the remaining 12 patients. Likewise, El Ghouzzi et al. 
(l997b) reported patients classified as Saethre-Chotzen to have the 
FGFR3 Pro250Arg mutation but noticed the milder phenotype in these 
patients as compared to TWIST ones. It was therefore concluded that 
TWIST mutations are specific to Saethre-Chotzen syndrome. Given 
the overlapping clinical features of the different craniosynostosis 
syndromes it indeed seems more sensible to rediaguose these FGFR3 
Pro250Arg patients. With nearly half of the patients matching the 
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classical description of Saethre-Chotzen having a TWIST mutation, 
this genetic alteration could be a pathognomonic criterion for Saethre-
Chotzen syndrome, or to rename this condition as TWIST-
craniosynostosis syndrome. The phenotype of TWIST-mediated 
Saethre-Chotzen syndrome consists of coronal suture synostosis (uni-
or bilateral), facial asynunetry, low frontal hairline, and eyelid ptosis 
besides syndactyly of the second and third fingers, duplicated 
halluces, prominent ear crura, and small, posteriorly rotated ears 
(Johnson et al., 1998; Zackai and Stolle, 1998). These features could 
not be correlated to particular mutations within TWIST (El Ghouzzi et 
aI., 1999), but perhaps with a higher number of patients this group can 
be further subdivided in future. In some cases, metopic suture 
synostosis was observed, although always associated with other 
typical features of Saethre-Chotzen (paznekas et aI., 1998; Johnson et 
aI., 1998). In the cases with a deletion of 7p21.1 the three patients 
with large (> 3 Mb) deletions had significant learning difficulties 
which is relatively uncommon in TWIST positive patients, suggesting 
that haploinsufficiency of the genes that neighbor TWIST contributes 
to mental handicap (Johnson et aI., 1998). 
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Table 1. List of published mutations in the FGFRl, FGFR2, FGFR3, 
and TWIST genes related to craniosynostosis. 
Abbreviations: A = Apert; AN = acanthosis nigricans; BS = Beare-
Stevenson; C = Crouzon; JW = Jackson-Weiss; N = normal; NS = 
non-syndromic craniosynostosis; P = Pfeiffer; RS = Robinow-Sorauf; 
SCh = Saethre-Chotzen; U = unclassified. 
When author's names are separated by a "/" this means that both have 
reported the same associated clinical diagnosis more or less 
simultaneously. 
FGFRI 
mutation diagnosis 
Muenke (1994) Pro252Arg P 
FGFR2 
Source mutation diagnosis 
Exonilla 
Pulleyn (1996) TyrlO5Cys C 
Wilkie (1995b) Ser252Trp A 
Passos-Bueno (1998b) " P 
Oldridge (1997) Ser252Phe A 
Oldridge (1997) Ser252Leu C,N 
Oldridge (1997) Ser252PheIPro253Ser P 
Wilkie (I 995b ) Pro253Arg A 
Oldridge (1995) Ser267Pro C 
Cornejo-Roldan (1999) " P 
Meyers (1996) Thr268ThrGly C 
paznekas (1998) Va1Va1269-270del SCh 
Steinberger (1998) Phe276Val C 
Cornejo-Roldan (1999) P 
Oldridge (1995) Cys278Phe C 
Meyers (1996) P 
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Source mutation diagnosis 
Passos-Bueno (1998a) Cys278Phe JW 
Oldridge (1995) deIHisIleGIn 287-289 C 
Cornejo-Roldan (1999) Ile288Met and 289-294"" P 
Oldridge (1995)/Gorry (1995) G1n289Pro C 
Meyers (1996) " JW 
Park (1995) Trp290Gly C 
Oldridge (1995) Trp290Arg C 
Tartaglia (1997a) Trp290Cys (a--.C) P 
Wilkie (I 997)/Schaefer (1998) Trp290Cys (a--.1) P 
Steinberger (1997) Lys292Glu C 
Steinberger (1998) Tyr30lCys C 
ExonIDc 
Steinberger (1998) Ala314Ser U 
Lajeunie (1995b) Asp321Ala P 
Jabs (1994) Tyr328Cys C 
Steinberger (1996b) Asn331Ile C 
Steinberger (1996b) dup336-337 C 
Passos-Bueno (I 998a) Ala337Pro C 
Gorry (1995) Gly338Arg C 
Pulleyn (1996) Gly338Glu C 
Reardon (1994) Tyr340His C 
Cornejo-Roldan (1999) Tyr340Cys P 
Rutland (1995) Thr341Pro P 
Reardon (1994) Cys342Tyr C 
Rutland (1995) P 
Reardon (1994) Cys342Arg C 
Schell (I 995)lRutiand (1995) P 
Park (1995) " JW 
Reardon (1994) Cys342Ser (T---7A) C 
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Source mutation diagnosis 
Meyers (1996) Cys342Ser (T--.>A) P 
Tartaglia (1997b) " JW 
Gorry (1995) Cys342Ser (G-->C) C 
Meyers (1996) P 
Tartaglia (1997b) JW 
Cornejo-Roldan (1999) Cys342Ser (GC--.>CI) P 
Oldridge (1995) Cys342Phe C 
Park (1995)/Ma (1995)/Stein-
berger (1995) Cys342Trp C 
Hollway (1997) " P 
Cornejo-Roldan (1999) Cys342Gly P 
Meyers (1996) Ala344Pro P 
Jabs (1994) Ala344Gly JW 
Gorry (1995) " C 
Reardon (1994) Ala344Ala C 
(new donor splice site) 
Steinberger (1996a) " U 
Meyers (1996) P 
Jabs (1994) Ser347Cys C 
Oldridge (1999) 1041-1042 insAlu A 
Pulleyn (1996) Ser35lCys U 
Gripp (1 998a)/Mathijssen (1998) P 
Reardon (1994) Ser354Cys C 
Meyers (1996) Va1359Phe P 
Steinberger (1996b) dell 078-1086 C 
Cornejo-Roldan (1999) 1084+ 3A--.>G P 
Schell (1995) 940-3T--.>G P 
Schell (1995)/Lajeunie (1995b) 940-2A--.>G P 
Cornejo-Roldan (1999) 940-lG-->A P 
Hollway (1997) 940-lG--.>C P 
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Source 
Schell (1995) 
Oldridge (1999) 
Transmembrane domain (exon 10) 
Przylepa (1996) 
Przylepa (1996) 
Pulleyn (1996) 
FGFR3 
Bellus (1996) 
Meyers (1995) 
TWIST 
Source 
Upstream of DNA binding 
Gripp (2000) 
Rose (1997) 
Rose (1997) 
Johnson (1998) 
Gripp (2000) 
Kasparcova (1998) 
Kasparcova (1998) 
Howard (1997) 
EI Ghouzzi (1997a) 
Paznekas (1998) 
EI Ghouzzi (I 997b) 
mutation 
1119+IG--+T 
1119-3- -4insAlu 
Ser372Cys 
Tyr375Cys 
G1y384Arg 
mutation 
Pr0250Arg 
Ala391Glu 
mutation 
G1n28STOP 
G1y6ISTOP 
G1u65 STOP 
Lys77Ser + frame shift 
Gly88Ala + 36aa to stop 
GAGGGGG92-92ins 
Ser93Gly + 198aa to stop 
Tyrl03STOP (308insA) 
Tyrl03STOP (309C--+A) 
Tyrl 03 STOP (309C--+G) 
Glu!04STOP 
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diagnosis 
P 
A 
BS 
BS 
U 
diagnosis 
NS,P,C,SCh 
C+AN 
diagnosis 
SCh 
SCh 
SCh 
SCh 
SCh 
SCh 
SCh 
SCh 
SCh 
SCh 
SCh 
Source mutation dia@osis 
DNA binding 
Paznekas (199S) Arg116Trp SCh 
El Ghouzzi (l997b) ArgllSGln/Arg11Sdel SCh 
Rose (1997) ArgllSHis SCh 
El Ghouzzi (1999) ArgllSHis (delS bp) SCh 
Ray (1997) Gin II9Pro SCh 
Kasparcova (199S) Arg120Pro SCh 
Helix I 
Paznekas (199S) Gln122STOP SCh 
E1 Ghouzzi (1997a) Ser123STOP SCh 
Johnson (199S) Ser123Trp SCh 
El Ghouzzi (1997a) G1u126STOP SCh 
Gripp (2000) Alal27Val SCh 
paznekas (I 99S) Ala129Arg+ 159aa to stop SCh 
E1 Ghouzzi (I 997a) Leu131Pro SCh 
paznekas (199S) Arg132Pro SCh 
Rose (1997) Ile134Met SCh 
Howard (1997) AALRKIl135-136ins SCh 
Johnson (199S) Pro136Leu U 
Loop 
El Ghouzzi (1997a)lHoward (1997) KIlPTLP139-140ins 
(416dup21) SCh 
El Ghouzzi (1997 a) KI1PTLP139-140ins 
(417dup21) SCh 
Rose (1997) Pro139STOP (419dup21) SCh 
paznekas (199S) Pro139Ser SCh 
Rose (1997) Serl40STOP SCh 
Rose (1997) IIPTLPS 140-141 ins SCh 
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Source mutation dia@osis 
paznekas (1998) Asp14ITyr SCh 
Rose (1997) Asp141Gly SCh 
El Ghouzzi (1999) DHPHAALGl41-142ins SCh 
El Ghouzzi (1999) Serl44Arg SCh 
Rose (1997) Lys145Asn SCh 
El Ghouzzi (1997b) Lys145Glu + 135aa to stop SCh 
Howard (1997) Lys145Gly SCh 
Ray (1997) Thr148Asn SCh 
Kasparcova (1998) Thr148Ala SCh 
Paznekas (1998) Leu149Phe SCh 
Paznekas (1998) Ala152Val SCh 
Helix II 
Rose (1997) Arg154Gly SCh 
Kunz (1999) Arg154Lys RSISCh 
El Ghouzzi (1999) Tyr155STOP SCh 
El Ghouzzi (1997b) Leu159Phe SCh 
Kasparcova (1998) Tyr160stop SCh 
El Ghouzzi (1997b) Gln161STOP SCh 
El Ghouzzi (1999) Leu163Phe SCh 
Gripp (2000) Gln165STOP SCh 
Gripp (1999) Glu181 STOP SCh 
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Expression and function of FGFRs and TWIST during skull 
development 
Before the involvement of FGFRs and TWIST in skull development 
through craniosynostosis was recognized studies on their expression 
pattern and function only focused on the early stages of 
embryogenesis. Currently, these data are partially gathered for the 
FGFRs (Iseki et a1., 1997; Kim et a1., 1998; Mehrara et a1., 1998; Iseki 
et a1., 1999). Within the coronal suture of murine embryos aged 15 
days post conception (EIS), FGFRI expression was detected in the 
osteogenic fronts of the calvarial bone (Rice et a1., 2000). From EIS 
on, FGFR2 was expressed by osteogenic precursor cells at the 
extensions of the frontal and parietal osteogenic fronts (Iseki et a1., 
1997). Towards the osteogenic fronts the cells were more 
differentiated with subsequent down-regulation of FGFR2 and up-
regulation of FGFRI (Iseki et a1., 1999). Functionally, FGFR2 
expressIOn correlated with a high proliferation rate, while FGFRI 
expression indicated bone differentiation. When differentiation of 
these cells was even more advanced FGFRI was no longer expressed, 
indicating that FGFRI is only taking part in the osteogenic 
differentiation process and not in maintaining the differentiated state 
(Iseki et a1., 1999). FGFR3 expression can be traced within the 
cartilage situated underneath the coronal suture as well as in 
osteogenic cells of the suture. Within the suture, FGFR3 had a similar 
localisation to that of FGFR2 and a co-operative role between FGFR2 
and FGFR3 in osteogenic cell proliferation has been suggested (Iseki 
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et aI., 1999). Figure 4 summarizes the expression patterns ill the 
coronal suture at E 16. 
05feopontfn _ 
Fgfr1 _ 
Fgfr2 _ 
Fgfr3 _ 
osteoid Skin 
~====~ 
Parieta l Bone 
Brain 
Figure 4. Schematic drawing of a coronal suture of a mouse embryo 
16 days post conception, indicating the expression ofFGFRI, 2 and 3. 
The function of FGFR3 detected in a plate of cartilage underlying the 
coronal suture is unclear, just like the fate of the cartilage itself. 
Within the coronal suture, a balance between proliferation (FGFR2, 
FGFR3) and bone differentiation (FGFRI) appears to be kept to 
ensure its function. 
FGF2 is nearly absent in the center of the suture, while its 
concentration rises towards the osteogenic fronts being highest in the 
osteoid. FGF9 is also detected in this region (Kim et aI. , 1998) while 
FGF4 (Kim et aI., 1998; Iseki et aI., 1997) and FGF8 (Yoshiura et aI., 
1997) are not. So it appears that FGF2 might be one of the factors 
regulating the proliferation/differentiation balance. A limited number 
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of studies concerning the FGFRs expression have been performed on 
human tissues. Delezoide et al. (1998) detected FGFRI and FGFR2 
expression prior to the onset of ossification within the mesenchyme of 
the presumptive skull bones. Likewise, Chan and Thorogood (1999) 
traced FGFR2 in the membrane bones ofthe skull in a human embryo 
of 12 weeks postfertilization, while FGFRI was mainly expressed in 
the periosteum. Data on FGFR3 or TWIST patterns in human material 
are lacking. 
TWIST expression during skull development in mouse embryos is 
confined to the calvarial mesenchyme (mesenchymal cells and 
osteoprogenitor cells) in between the frontal and parietal bones, with 
its strongest expression directly neighboring the osteogenic fronts 
(Rice et aI., 2000). This pattern is clearly outlined starting from E14. 
TWIST has been shown to regnlate FGFR, functioning upstream of 
FGFRlFGF signalling (Rice et aI., 2000). 
Another process that might be involved III maintaining the 
proliferation/differentiation balance is programmed cell death or 
apoptosis (Rice et al., 1999). In 1977, Ten Cate and coauthors 
reported on the presence of apoptotic cells in the suture of newborn 
rats. Furtwangler and others (1985) considered apoptosis to be a 
mechanism that prevented fusion of bones, a hypothesis that we also 
believed to be true initially. Further studies on the involvement of 
apoptosis in the pathogenesis of craniosynostosis are presented in 
chapter IlL I and IIL2. 
Another unresolved aspect in suture biology is the function of the dura 
mater. It has been established that presence of the dura is essential to 
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keep the suture open (Opperman et al., 1993; Opperman et aI., 1995; 
Opperman et aI., 1996; Opperman et aI., 1997; Opperman et ai. 1998) 
probably through secretion of certain unidentified factors. 
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1.3. Aim of this study 
While craniosynostosis has been treated for almost thirty years a 
number of dilemmas are still encountered, related to clinical practice 
and fundamental knowledge. 
The first problem is that of correct diagnosis. A distinction should be 
made between a true isolated case of craniosynostosis and a 
syndromic form. In clinical practice a case is considered to be isolated 
when the suture synostosis is the only malformation present. Most 
commonly, these patients are the only affected individual within the 
family. In the presence of overt deformities of the face andlor 
extremities a syndromic form is easily recognized. The apparent 
isolated cases of craniosynostosis are the challenging ones, in whom a 
syndrome may be difficult to distinguish (Tartaglia et aI., 1999). Once 
a syndromic form is acknowledged the difficulty in designating the 
most appropriate syndrome within the classical classification system 
remains, for which the pitfalls have been discussed earlier (chapter 
I.l). Given the possible impact of the diagnosis on care, a conclusive 
classification is desirable which covers both phenotype and genotype. 
The second problem concerns the pathogenesis of this congenital 
malformation about which little is known. A wide range of suggested 
causes have been reported but none could be proven. The discovery of 
genetic defects that underlie craniosynostosis syndromes has shed 
some light on its etiology, although it generated even more questions. 
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Given these two dilemmas, our research set out to deal with the first 
and most basic problem, that of classification. At that time the first 
gene defect related to craniosynostosis was located (Reardon et aI., 
1994). Our approach was that of a morphological study of the cranium 
(chapter II.!; Vaandrager et aI., 1995). Although the morphometric 
data did not bring a guideline for classification they did direct us 
towards the pathoembryogenesis of craniosynostosis. Based upon 
these results a hypothesis was developed on bone center displacement 
during skull development being the primary defect III 
craniosynostosis. However, testing this theory in a rabbit strain 
suffering from inborn coronal suture synostosis showed this theory to 
be wrong (Dechant et aI., 1998; Mooney et aI., 1998; Dechant et aI., 
1999). Bone centers arose at their normal position and it was not 
before the onset of suture ossification, i.e., bone fusion that the bone 
centers became displaced. 
Based on observations done on normal human fetal skulls the timing 
and pattern of metopic, coronal, sagittal and lambdoid sutures 
development was described. In our patients the distance between the 
bone centers of the fused bones correlated directly to the fetal stage at 
which craniosynostosis arose (chapter I1.2). Although this may be of 
clinical relevance such as prenatal screening through ultrasound, no 
relevant classification could be extracted from these data. Meanwhile, 
the first mutated genes in craniosynostosis were located, revealing the 
involvement of the FGFRs and TWIST in the development of the 
skull. 
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With the advances made in the genetic field on craniosynostosis, a 
new basis for classification was thought to be found. Unfortunately, 
the correlation between genotype and phenotype for most mutations 
was not as strict as hoped for. Even so, this correlation is of clinical 
relevance because it might offer the possibility to screen and treat 
patients more accurately, while genetic counseling is more acurate. 
This, however, needs to be substantiated by further analysis. In this 
respect, we reported the clinical findings in one patient with the 
Ser351Cys mutation in FGFR2 (chapter IV.I) and those of two 
families with the Pro250Arg mutation in FGFR3 (chapter IV.2). 
Besides the studies undertaken for classification purposes, our 
research was also directed towards the pathogenesis of 
craniosynostosis. Until recently, studies on suture development and 
biology were hardly available (Pritchard et aI., 1956; Markens 1975; 
Decker and Hall, 1985). Understanding how a congenital disorder is 
initiated requires full understanding of normal development. For this 
reason we analyzed histological samples of coronal sutures of murine 
fetuses and embryos (chapter III.!). The coronal suture was chosen 
since this suture is most commonly affected in syndromic cases of 
craniosynostosis. Because apoptosis is known to be of vital 
importance during normal embryogenesis and disturbances of this 
process have been implicated in congenital malformations such as 
syndactyly, the focus was on the occurrence of this process during 
suture development. Our next investigation was to evaluate the 
consequences of the FGFR mutations on the developmental biology of 
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the coronal suture. Unfortnnately, no animal with a comparable FGFR 
mutation is known. The craniosynostotic rabbits from Pittsburgh 
might carry a FGFR mutation but this has not been confIrmed. 
Therefore, an alternative model was needed. A number of reports had 
shown most of the FGFR mutations to result in an up-regulation of the 
receptor function. We mimicked this effect in an in vivo mouse-model 
by injection of FGF4 or FGF2, ligands of FGFR2, locally near the 
developing coronal suture through ex utero surgery (Mathijssen et aI., 
1999; chapter III.2). 
In short, we had high set goals at the start of this study by trying to 
establish a conclusive classifIcation for craniosynostosis. Due to the 
developments in the genetic fIeld and as a result of our initial study, 
our focus shifted towards the pathogenesis of craniosynostosis. The 
potential of genetic mutation analysis for being the basis of a new 
classifIcation was explored, to which we contributed in describing the 
geno-phenotypic relationship for 2 mutations (chapters IV.! en IV.2). 
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The Role of Bone Centers in the Pathogenesis 
of Craniosynostosis: An Embryologic 
Approach Using CT Measurements in Isolated 
Craniosynostosis and Apert and Crouzon 
Syndromes 
Irene M. J. Mathijssen, M.D., J. M. Vaandrager, M.D., J. C. van der Meulen, M.D., Ph.D., 
H. Pietennan, M.D., F. W. Zonneveld, Ph.D., S. Kreiborg, n.M.D., Ph.D., 
and C. Venneij-Keers, M.D., Ph.D. 
Rotterdam and Utrecht, The Netherlands, and Copenhagen, Denmark 
This paper describes the role of the displacement of 
bone centers, Le., the tubers, in the pathogenesis of cra-
niosynostosis. This displacementwas studied in 54 patients 
with isolated or syndromic craniosynostosis in the form of 
cr scans as well as in two dry neonate skulls with Apert 
syndrome. For comparison, 49 fetal and 8 normal infant 
dry skulls were studied. OUf investigation was restricted to 
the coronal and metopic sutures. The results showed a 
significandy more oCcipital localization of the frontal 
bone center and a more frontal localization of the parietal 
bone center at the side of a synostotic coronal suture in 
the isolated form as well as in Apert syndrome. In contrast, 
this was not the case in Crouzon syndrome, thus showing 
that these twO syndromes have a different pathogenesis. 
For trigonocephaly, a more anteromediallocalization of 
the frontal bone centers was found. (Plast. Reconstr. Surg. 
98: 17, 1996.) 
Craniosynostosis is generally considered as a 
premature closure of cranial sutures resulting 
in cranial deformity.' One of the classifications 
of craniosynostosis designates the isolated and 
the syndromic craniosynostoses.2 In the isolated 
fonn, no other abnormalities, except those 
which may occur secondary to early sutural 
obliteration, are found, e.g., unilateral or bilat-
eral coronal suture synostosis and metopic su-
ture synostosis. In syndromic craniosynostosis, 
other primary defects of morphogenesis occur. 
The Apert and Crouzon syndromes are exam-
ples of this latter group. 
Little is known about the pathogenesis of cra-
niosynostosis. Genetics plays an important role, 
and recently, the genes for Apert, Crouzon, 
Pfeiffer, and Saethre-Chotzen syndromes have 
been located.3-6 Craniosynostosis is considered 
to be a late developmental defect during em-
bryogenesis (<'::17 mm crown-rump length) .'-' 
Our goal in this study was to explain the etiology 
of coronal and metopic suture synostosis from 
an embryologic point of view in both the iso-
lated and the syndromic forms. 
EMBRYOLOGY 
During normal development of the skull, the 
frontal bone and both parietal bones are 
formed by ossification of membrane anlagen. 
The frontal bone starts to ossify in a pair of bone 
centers, one left and one right, and each pari-
etal bone in two fusing bone centers.lO,ll Ac-
cording to several authors, the frontal bone 
centers arise in the developmental stage of26 to 
35 mm crown-rump length,9,12-15 and the pari-
etal bone centers arise in stage 31 to 45 mm 
crown-rump length.',12-14 Subsequently, ossifi-
cation extends radially toward the margins with 
the tubers, being the most prominent portion 
of the bone, situated in the center of the thus 
formed radiating growth pattern of the 
bone.1l ,16 According to Gray's Anatomy16 and 
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Trotter and Peterson,17 the original position of 
the frontal and parietal bone centers is repre-
sented by the frontal and parietal tubers, re-
spectively, while Inman and Saunders, 11 
Starck,14 Hinrichsen,Is and Macklinl9 do not ad-
here to this statement. Inman and Saunders, 11 
for example, situated the frontal bone centers 
in the superciliary region. 
Normally, the metopic suture, formed by the 
frontal bone centers, ossifies during the second 
year of life. The coronal suture, developed bi-
laterally by the frontal and fused parietal bone 
centers, begins to close at 24 years of age.20 
Apoptosis (programmed cell death) appears to 
prevent fusion of bone centers and therefore 
causes the existence of the sutures.9,21 
On abnormal development of the skull, the 
literature reports agenesis of the bone centers 
with subsequent agenesis of the involved 
bone7,22-25 and failure of bone centers to fuse 
where they normally do, resulting in the for-
mation of an extra suture, e.g., the bipartite 
parietal bone.26-28 An extra bone center within 
one bone also can cause an extra suture, as is 
seen in the bipartite zygomatic bone.8,9 Trigo-
nocephaly was described as the result of the 
frontal bone developing from one single bone 
center.8 Moreover, Vermeij-Keers9 has sug-
gested that craniosynostosis could be caused 
during embryogenesis by direct fusion of bone 
centers. Describing the infant Apert skull, 
Kreiborg and Cohen29 mentioned that proper 
sutures do not form in the coronal or sagittal 
areas. Because of this sutural agenesis, adjacent 
centers of ossification would no longer be pre-
vented from coalescing, resulting in bony fu-
sion across coronal suture areas. Furthermore, 
Wrete30 noted the lack of both the frontal and 
parietal tubers in bilateral synostosis of the 
coronal suture and the lack of frontal tubers in 
trigonocephaly, but without drawing any con-
clusions from his finding. 
It is postulated here that during embryogen-
esis, adjacent bone centers, being displaced to-
ward the synostotic suture, can undergo direct 
fusion of these bone centers. Subsequently, 
there is no development of the coronal suture, 
for example, at this level. This malformation 
can occur unilaterally in unilateral coronal su-
ture synostosis and bilaterally in bilateral coro-
nal suture synostosis and in Apert syndrome. 
Basically the same mechanism occurs when 
both bone centers of the frontal bone are lo-
cated more anteromedially. Direct fusion be-
tween them takes place, without formation of 
the metopic suture, giving rise to a trigonoce-
phalic skull. 
COMPUTED TOMOGRAPHY 
Computed tomography (CT) has been shown 
to be a very sensitive method for detecting cra-
niosynostosis.31 Sutures of the calvaria are most 
accurately identified on high-resolution CT 
scans, using 1.5- or 2.O-mm-thick sections,32 de-
pending on the type of scanner. Three-dimen-
sional reconstruction from CT images is of gre'at 
value in understanding the pathologic mor-
phology of the patient and in the preparation 
for craniofacial surgery.33-35 
Craniofacial measurements obtained from 
CT scans are accurate and reproducible. 36,37 
The technique is easy to master, and the objec-
tive data obtained can be used to assist in di-
agnosis, guide preoperative planning, and doc-
ument results after surgical correction.37- 41 
Waitzman et al. 42 created a base of normative 
CT data for the upper part of the craniofacial 
skeleton. Carr et al. 43 compared these values 
with measurements derived from patients with 
Apert and Crouzon syndromes under the age of 
1 year and in addition compared Apert with 
Crouzon syndrome. Data from their study, how-
ever, did not show major differences between 
patients with the Apert and Crouzon syndromes 
despite morphologic differences. According to 
Carr et al.43 and Kreiborg and Pruzansky,44 mea-
surements in other planes or of other structures 
are necessary to differentiate the morphology 
of these syndromes quantitatively. 
By studying dry skulls, dry-skull CT scans, and 
CT scans derived from patients with craniosyn-
ostosis, we have evaluated the relationship be-
tween tubers and bone centers, as well as their 
involvement in coronal and metopic suture syn-
ostosis in the isolated form, in Apert and Crou-
zon syndromes. New CT measurements, based 
on our suggested embryologic etiology for coro-
nal and metopic suture synostosis, are intro-
duced. 
MATERIALS AND :METHODS 
Sul1ects 
In order to study the involvement of the fron-
tal and parietal tubers and bone centers in coro-
nal and metopic suture synostosis compared 
'with normal, macroscopic observations were 
performed of 49 normal fetal dry skulls (rang-
ing in age from 15 to 40 weeks), eight nonnal 
dry skulls ofinfants (estimated age I to 4 years), 
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and two dry neonatal Apert skulls of the tera-
tologic collection of the Museum of Anatomy of 
Leiden University. Unfortunately, no infant dry 
Crouzon skulls were available. 
To trace the tubers on a CT scan in an an-
teroposterior direction, we first marked the 
frontal and parietal tubers with clay before tak-
ing the axial CT scan. This procedure was done 
for one normal fetal skull (approximately 6.5 
months) and for the two Apert skulls. Based on 
the findings of these scans, we developed new 
CT measurements for locating the tubers. This 
enabled us to locate the frontal and parietal 
tubers on CT scans of our patients. 
To validate this method, a comparison of the 
results oflocating the tubers on the dry-skull CT 
scans using our new measurements with iden-
tifying them by clay marking was made. 
A retrospective study of CT scan series of 54 
patients with an isolated or syndromic cranio-
synostosis was undertaken using our new vari-
ables. Only complete, good-quality CT series of 
unoperated children, ranging in age from 1 
month to 20 years, were selected. The age and 
gender distributions of the samples under study 
are outlined in Table I. 
The scans had been made for the purpose of 
three-dimensional imaging. The population 
under study was classified according to the syn-
ostotic sutures, with Apert and CrotiZon syn-
dromes kept separate, the metopic suture being 
considered synostotic only if it had resulted in 
a trigonocephalic configuration of the skull 
(Table II). 
In order to compare the measurements for 
the synostotic with those for open coronal and 
metopic sutures, each suture was classified as 
being open, synostotic, or uncertain. Four of 
the 54 patients had a synostotic metopic suture, 
TABLE I 
Age and Gender Distribution of Patients 
Age Category 
0-3 months 
4-6 months 
7-9 months 
10-11 months 
1 Y""" 
2 years 
3 years 
4 years 
5 years 
7 years 
13 years 
20 years 
TOTAL 
Females M"~ 
6 5 
8 
, 3 , 5 
5 4 
2 1 
1 
25 29 
To"" 
11 
13 
5 
7 
9 
3 
1 
54 
TABLE II 
Population Under Study, Classified According to the 
Synostotic Sutures, Apart from Apert and Crouzon 
Syndromes 
Synostotic Suture(s) 
Coronal, unilateral 
Coronal, bilateral 
Sagittal 
lambdoid 
Metopic 
Lambdoid + metopic 
TOTAL 
No, of 
Patiellt.s 
9 
7 
10 
8 
10 
6 
3 
54 
Syndrome Illvolved 
Apert 
Crouzon 
resulting in a trigonocephalic skull. Of the re-
maining 50 patients, 100 coronal sutures were 
classified; 42 were synostotic, 43 were open, and 
for 15 ossification was uncertain (Table III). 
Since no CT scans obtained by the same pro-
cedures were available of normal, age-matched 
controls, we compared open with synostotic su-
tures within our popUlation of patients. 
Computed Tomographic Procedures 
The axial CT scans of the dry skulls were 
taken with a Siemens Somatom Plus VD30 CT 
scanner using 2.0-mm slices (DepartmentofRa-
diolog)', University of Rotterdam). Axial CT 
scans of the patients were obtained with a Phil-
ips Tomoscan LX CT scanner and a Philips 
Tomoscan 350 using 1.5-mm contiguous slices. 
General anesthesia was used for children under 
age 12 (Department of Radiology, University of 
Utrecht). 
Measurements 
The four new variables in the cranial region 
(Table N) were measured and standardized 
with reference to the 5-cm scale bar on each 
film. For that purpose, we first made a copy of 
the required slice in order to measure more 
precisely. To obtain data, the slice transecting 
the most anterolateral points of the lateral ven-
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TABLE III 
Classification of the Studied Coronal Sutures after 
Separating Patients with Trigonocephaly (n =: 100) 
Synostotic Op.o Ullcertain 
Apert 18 
Crouzon 3 5 6 
Other 21 38 9 
TOTAL 42 43 15 
TABLE IV 
Computed Tomographic Measurements of the Bone Centers 
Measurement Description 
Frontal bone center angle 
Frontal bone center distance 
Sharpest angle, left and right sides, at the frontal bone (see Fig. 4a) 
Distance between the frontal bone center angle and the most frontal point of the outer 
table of the skull (see Fig. 40) 
Parietal bone center angle 
Parietal bone center distance 
Sharpest angle, left and right sides, at the parietal bone (see Fig. 4c) 
Distance between the parietal bone center angle and the most frontal point of the OUter 
table of the skull (see Fig. 4d) 
trides and the occiput above the inion was used, 
according to Waitzman et al.42 
Measurements of the four variables were re-
peated by the same person on MO separate oc-
casions to check intraobserver reproducibility. 
Statistical Analysis 
Statistical differences bet:\veen group means 
were tested by Student's t test Group means, 
standard deviations, and 95 percent confidence 
intervals were calculated for the measurement 
variables. Test statistics associated with proba-
bilities of 0.05 or less were considered signifi-
cant, and all probability (p) values were t:\vo-
sided. 
REsULTS 
Macroscopic Obseroations 
Macroscopic observations of the fetal and in-
fant skulls dearly showed the radiating growth 
pattern of the frontal and parietal bones with, 
respectively, the frontal and parietal tubers in 
the center, as can be seen in Figure 1. This 
radiation was seen best in the fetal skulls, re-
maining visible until the age of approximately 
1 Y2 years with respect to the frontal bone and 4 
years for the parietal bones. The position of the 
tubers, however, was very consistent. 
Both Apert skulls dearly showed an abnormal 
radiating growth pattern of both frontal and 
parietal bones (Fig. 2) and a displacement of 
the tubers, being situated in the center of this 
pattern. The frontal tuber is situated more pos-
terocaudally and the parietal tuber more an-
terocaudally. In between the frontal and pari-
etal tubers the radiating growth pattern is 
absent, and fusion of the bones took place, in-
stead of the expected normal development of 
the coronal suture. The coronal suture was 
formed cranial and, to a much lesser extent, 
FIG. 1. Dry skull of a fetus showing the radiating growth pattern of the frontal and parietal 
bones with the frontal and parietal tubers in the center. 
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FlG. 2. Dry skull of Apert syndrome. Note the abnormal radiating growth pattern of both 
frontal and parietal bones in the Apert skull compared with normal (Fig. 1). The coronal suture 
had been developed only cranial and caudal to the side of fusion (arrows). 
caudal to the locus of fusion. All abnormalities 
described were seen bilaterally. 
Computed Tomography 
On all scans of the three dry skulls, the c1ay-
marked tuber, i.e., bone center, was found near 
the sharpest angle of the bone concerned (Fig. 
3). This suggests that the frontal and parietal 
tubers can be located on a CT scan at the site 
of the sharpest angle of the frontal bone and the 
parietal bone, respectively, on the left and right 
sides. We measured this bone center angle as well 
as the distance between this point and the most 
frontal point of the outer table of the skull, the 
bone center distance (see Table IV). 
In order to validate this method of measure-
mentfor locating the bone centers, the distance 
between the clay and the most frontal point of 
the outer table of the skull also was measured on 
the CT scan and compared with the previously 
described bone center distance (Table V). 
The preceding comparison between both 
methods of measurement resulted in a mean 
difference of 0.3 mm 'With a 95 percent confi-
dence limit of -1.2 to 1.9. This indicates that by 
identifying the bone center angle on CT scan, 
a good method for marking the position of the 
bone center in the anteroposterior direction 
has been obtained. These variables enabled us 
to locate the bone centers on the CT scans of 
our 54 patients. 
Figure 4 shows how measurements were 
taken from the CT scans of patients with iso~ 
lated unilateral synostosis of the coronal suture 
( 4.1), Apert syndrome ( 4. 2), Crouzon syn-
drome (4.3), and isolated synostosis of the 
metopic suture (4.4). 
Means and standard deviations were com~ 
puted for each variable for gender. There were 
no significant differences for gender; with re-
spect to the frontal bone center distance, the 
mean difference was 4.2 mm with 95 percent 
confidence limits of -0.7 to 9.1, and for the 
parietal bone center distance, the mean differ~ 
ence was 5.5 mm with 95 percent confIdence 
limits of -2.3 to 13.3, so data were pooled. 
The mean frontal bone center angle was 157 
degrees, and the mean parietal bone center 
angle was 164 degrees. Intraobserver measure-
ments of the frontal bone center distance re-
sulted in a mean difference of 0.4 mm with a 95 
percent confidence interval of 0.0 to 0.9. For 
the parietal bone center distance we found a 
mean difference of 0.2 mm with a 95 percent 
confidence interval of -0.4 to 0.8. Bone center 
distances and age did not correlate. 
There was no statistical difference found be-
tween isolated synostotic coronal sutures and 
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Frc. 3. CT scans taken from a normal fetal dry skull 
(above) and an Apert dry skull (below) with the clay indicating 
the frontal tuber. i.e., bone center. 
Apert syndrome for both mean frontal and 
mean parietal bone center distances (the 95 
percent confidence interval of the mean differ-
ence in frontal bone center distance was -0.6 
to + 11.0 mm; for parietal bone center distances 
the confidence interval was -3.1 to +20.1 mm). 
Therefore, data on isolated synostotic coronal 
sutures and Apert syndrome were pooled, col-
lectively forming the synostotic group (Table 
VI). 
Table VI presents the mean values for mea-
surements of the frontal and parietal bone cen-
terS. The 95 percent confidence intervals for 
the frontal and parietal bone center distances 
for synostotic coronal sutures were not overlap-
ping with those for open coronal sutures. This 
implies a statistically significant more posterior 
localization of the frontal bone center and a 
more anterior localization of the parietal bone 
center at the side of the synostotic coronal su-
ture in the isolated form as well as in Apert 
syndrome. In contrast, this was not the case in 
Crouzon syndrome. The obsenred synostosis of 
the coronal sutures in Crouzon syndrome can 
therefore not be explained by a displacement of 
the bone centers. 
For trigonocephaly, a more medial localiza-
tion of the frontal bone centers was found, with 
a normal position of the parietal bone centers 
in an anteroposterior direction. 
DISCUSSION 
The combination of an abnormal radiating 
growth pattern and displaced tubers together 
with fusion of the frontal and parietal bones in 
between these tubers instead of coronal suture 
development, found bilaterally on the dry Apert 
skulls, shows a close relationship between the 
localization of the tubers and bone centers in-
volved. This finding suggests that the tubers do 
indicate the original position of the bone cen-
ters, as was stated in Gray's Anatomy16 and by 
Trotter and PetersonP 
The presented CT measurements enabled us 
to locate the frontal and parietal bone centers 
on CT scans in an anteroposterior direction. 
The results of these measurements are in line 
with our theory that synostosis of coronal and 
metopic sutures can be explained by an abnor-
mal localization of the bone centers involved. 
Because of this displacement, the bone cen-
ters fuse, and subsequently, no suture is formed 
at this level. The partially developed suture, 
cranial and caudal to the site of fusion, ossifies 
gradually. Rather than premature ossification 
of an established suture, as is implied by the 
term synostosis, this process is the result of a 
direct fusion of adjacent bone centers. Sutural 
agenesis, a term used previously by Kokich,20 
Furtwangler et al.,21 and Kreiborg and Cohen,29 
seems to be a more accurate description. 
In both the isolated form of coronal suture 
synostosis and Apert syndrome, in which bilat-
eral coronal suture synostosis is a constant find-
ing,29.45 a more posterior position of the frontal 
bone centers and a more anterior position of 
the parietal bone centers were found. In tri-
gonocephalic skulls, the bone centers of the 
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TASLEY 
Computed Tomographic Measurements of Bone Center Distance (mm) by Means of Clay Localization Compared with Bone 
Center Angle Localization 
Apen Ory Skull 1 Apert Dry Skull 2 Nonna! Fetal Dry Skull 
Clay Angle Clay Angle Cl'Y Angle 
Frontal bone center distance left 20 20 21.3 20 2.2 2.7 
Frontal bone center distance right 25 22.5 17.5 15 2.2 2.2 
Parietal bone center distance left 33.8 35.6 38.8 36.3 54.3 58.7 
Parietal bone center distance right 38.8 38.8 35.0 37.5 
'" 
48.9 
FIG. 4. Bone center measurements from axial CT scans: (4.1) plagiocephaly; (4.2:) Apert; (4.3) erOUZOD; (4.4) trigonocephaly. 
(a) Frontal bone centeranglej (b) frontal hone center distance; (e) parietal bone center angle; (d) parietal bone center distance. 
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TABLE VI 
Measurements of the Frontal and Parietal Bone Center Distance 
Frontal bone center dismnce 
Mean (mm) 
SD 
95% CI (mm) 
Parietal bone center distance 
Mean (mm) 
SD 
95% CI (mm) 
~ Coronal SUture. 
t Metopic SUtUre. 
:l: Number of measuremenrs. 
C1 '" confidence inteJVai. 
Open~,t 
(n'" 38): 
7.2 
3.3 
6.1-S.3 
95.0 
13.5 
90.5-99.4 
frontal bone are localized almost completely in 
the median plane. 
Apart from a displacement in the anteropos-
terior direction of the bone centers, our mac-
roscopic inspection of the two dry Apert skulls 
also suggests a more caudal dispositioning. 
Measuring the bone center distances in this 
direction requires coronal reformatting of the 
scans, which we are currently working on. We 
suggest that the same principle of dislocated 
bone centers applies to other types of cranio-
synostosis, which will be studied in subsequent 
research. 
Progressive calcification and fusion of the 
bones of the hands, feet, and cervical spine are 
known to occur in Apert syndrome.46,47 Harris et 
al.48 found abnormal epiphyseal ossification 
centers of the humerus and femur, fusion of 
calcaneus with cuboid, and fusion of the second 
and third metatarsal bones 'With other small 
bones in Apert syndrome and therefore sug-
gested a more generalized involvement of en-
chondral ossification. Cohen49 postulated that 
the same mechanism responsible for progres-
sive calcification throughout the body is also 
responsible for the associated craniosynostosis 
in Apert syndrome. Our findings of a displace-
ment of the ossification centers of the frontal 
and parietal bones in Apert syndrome make it 
seem likely that there is one basic ossification 
disorder for both enchondral and intramem-
branous ossification in this syndrome, probably 
leading to all the skeletal abnormalities ob-
served. 
The same abnormal localization of the fron-
tal and parietal bone centers in the horizontal 
plane present in Apert syndrome was found in 
isolated coronal suture synostosis. However, 
these patients do not present the calvarial mid-
line defect that is so characteristic of Apert syn-
Synostotic* Crouzon Trigonocephaly 
(n'" 39)l (n"" 14}:l: (n = 8}l 
30.6 9.7 1.9 
9.1 5.4 2.2 
27.7-33.6 6.6-12.8 0.0-3.7 
71.6 98.3 103.1 
22.6 23.2 10.5 
64.3-78.9 84.9-111.7 94.3-111.9 
drome. The caudal displacement of the bone 
centers observed in Apert dry skulls combined 
with true megalencephaly50 could possibly dis-
tinguish and explain the difference in pheno-
type. 
Whereas Carr et al.,43 using their technique, 
did not detect any major differences between 
patients with Crouzon and those with Apert 
syndrome, our measurements of the new vari-
ables presented enabled us to find a distinction. 
In contrast to Apert syndrome, the bone centerS 
in Crouzon patients were found not to be lo-
cated significantly different from their normal 
position, indicating that there is a different 
pathogenesis involved in causing premature 
closure of the sutures in Crouzon syndrome. In 
conclusion, the CT data presented here, differ-
entiating the morphology of the Apert and 
Crouzon syndromes, show a clear distinction in 
the pathogenesis of these tvvo syndromes. 
Chr. Vermeij-Keers, M.D., Ph.D. 
Department of Anatomy/Plastic and Reconstructive 
Surgery 
Academic Hospital Rotterdam 
Postbus 1738 
3000 DR Rotterdam 
The Nethe1-lands 
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Tracing craniosynostosis to its 
developmental stage through bone center 
displacement 
Mathijssen IMJ, van Splunder J, Vermeij-Keers Chr, Pieterman H, de 
long THR, Mooney MP, Vaandrager 1M. Tracing craniosynostosis to 
its developmental stage through bone center displacement. J Craniofac 
Genet Dev BioI 1999; 19:57-63. © Munksgaard, Copenhagen 
Abstract: In metopic and coronal suture synostosis, the involved bone 
centers are abnormally situated just next to the affected suture. Bone 
centers are the starting point of ossification during embryogenesis from 
which bone growth spreads radially. In this paper, we describe a simi· 
lar observation for sagittal suture synostosis, with both parietal bone 
centers located almost completely cranially. The (reduced) distance be-
tween the bone centers of a synostotic suture reflects the time during 
embryogenesis at which fusion took place. We suggest that in cran~ 
iosynostosis the bone centers arise in their nonnal position, and initial 
outgrowth is undisturbed until the bone fronts meet. It is during this 
developmental stage that fusion occurs instead of suture formation. 
Due to the fusion, growth can only occur at the free bony rims from 
then on. The bone centers remain located at a fixed distance from one 
another in the middle of the fused bones, becoming relatively more, 
displaced with time. This implies that the distance between the involved 
bone centers directly indicates the developmental period during which 
sutural growth was arrested. The same phenomenon of bone center 
displacement is found in types of craniosynostosis with and without 
fibroblast growth factor receptor (FGFR) or TWIST gene mutations. 
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Introduction 
Bone centers are the locus of first ossification of a 
certain bone during embryogenesis, arising on a 
specific position and at a specific time [Vermei} 
Keers, 1990]. Ossification spreads from the cal-
varial bone centers on, in a radial manner, giving 
rise to the radiating growth pattern of the bone 
plates. The original position of these bone centers 
is represented by the tubers, situated in the middle 
of the radiating growth pattern [Mathijssen et aI., 
1996; Richtsmeier et al., 1998]. 
observations on dry skulls, as well as by measure-
ments taken on computerized tomography (CT) 
scans of patients suffering from craniosynostosis. 
In our former study on calvarial morphology in 
craniosynostosis, we demonstrated bone center 
displacement to be present in isolated metopic and 
coronal suture synostosis, and in Apert syndrome 
[Mathijssen et al., 1996]. In metopic suture synos-
tosis, both frontal bone centers were located near 
the median. In isolated coronal suture synostosis 
and Apert syndrome, the frontal and parietal bone 
centers of the affected side(s) were situated near 
the affected suture(s}. These findings on bone cen-
ter position were demonstrated by macroscopic 
An increasing number of gene mutations have 
been related to craniosynostosis. Mutations in the 
fibroblast growth factor receptor (FGFR) genes 1, 
2, and/or 3 have been associated with Apert 
[Wilkie et aI., 1995], Crouzon [Reardon et aI., 
1994], Pfeiffer [Rutland et aI., 1995; Schell et aI., 
1995], and Jackson-Weiss syndromes [Gorry et 
al., 1995] and also with cases of non-syndromic 
coronal suture synostosis [Moloney et al., 1997; 
Muenke et .aI., 1997]. For Saethre-Chotzen syn-
drome, mutations in the TWIST [El Ghouzzi et 
aI., 1997; Howard et aI., 1997] and FGFR3 genes 
[paznekas et al. 1998] have been described. 
At present, it is unclear which developmental 
processes are affected by the products of these 
altered FGFR or TWIST genes and how cran-
iosynostosis is the ultimate result [Wilkie and 
Wall, 1996]. By studying embryologic landmarks, 
such as the bone centers, some aspects of these 
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processes can be elucidated. In our previous study 
on bone center positions in humans, we suggested 
that their displacement could be the primary de-
fect, inducing the synostosis. However, investiga-
tions on bone center positions during cranial 
development in rabbits suffering from coronal su-
ture synostosis showed this not to be the case 
[Dechant et aI., 1998, 1999; Mooney et aI., 1998J. 
Frontal and parietal bone centers had similar loca-
tions to those in non-affected animals up to the 
time of synostosis onset. Only afterwards the bone 
centers became displaced. 
Although not indicating the primary default, in 
the present study, we demonstrate that data on 
bone center positions can direct us towards the 
developmental period in which craniosynostosis 
originates. Comparison of the distance between 
the involved bone centers in the case of a synos-
totic suture and normal distances at different hu-
man developmental stages indicate the stage 
during which growth at the sutural area or suture 
was arrested. At that specific period, no suture was 
developed or the existing suture was obliterated 
and the bone plates fused. As a consequence, the 
distance between the bone centers was fixated and 
growth potential in that area was lacking. From 
then on, these bone plates started functioning as 
one solitary bone and growth could only take 
place at the free rims, thus adding to the relative 
degree of bone center displacement. This hypothe-
sis encorporates the fact that in craniosynostosis 
the distance between the bone centers is constant, 
not subject to the age of the patient, and reflects 
the developmental stage at which the fusion oc-
curred. To substantiate our theory, interbone cen-
ter measurements were undertaken in normal fetal 
dry skulls of various stages and in a patient popu-
lation with isolated and syndromic coronal suture 
synostosis. In addition, observations on bone cen-
ter positioning during surgery are reported for 
both coronal and sagittal suture synostosis. 
Materials and methods 
Dry skulls 
For both sides, the distance between the frontal 
bone center and ipsilateral parietal bone center 
was determined by taking measurements directly 
on the dry skulls of seven normal human fetuses 
ranging in age from 15 to 23 weeks of gestation. 
Age determination was based on the crown - heel 
length of the fetal skeletons. The bone centers 
were identified in the midpoint of the radiating 
patterns of the bones. Measurements were taken 
on both sides using vernier callipers and referred 
to as the interbone center distance (IBCD). The 
same measurements were performed on two dry 
neonatal Apert skulls with bilateral coronal suture 
synostosis. 
Perioperat'lve 
Bone center positions were determined semiquan~ 
titatively during each primary craniotomy per~ 
formed for correction of coronal or sagittal suture 
synostosis. Bone centers can easily be traced dur-
ing surgery by locating the center of the radiating 
growth pattern of the bone, which remains clearly 
visible in the infant. In total, observations were 
perfonned during 44 operations (one Apert, five 
Saethre-Chotzen, one Pfeiffer, 14 unilateral coro-
nal suture synostosis, 23 sagittal suture 
synostosis). 
Computerized tomography scans 
Patients. The axial CT scans were taken with a 
Siemens Somatom Plus VD30 CT scanner using 
2.0-mm slices. Only complete, good quality CT 
series of unoperated patients with isolated or syn-
dromic coronal suture synostosis were included. 
The CT scans of 54 patients were studied, 
classified according to their clinical diagnoses (12 
Apert, 12 Saethre-Chotzen, 2 Pfeiffer syndromes, 
18 unilateral and ten bilateral coronal suture 
synostosis). Measurements were taken from the 
scans, selecting the slice that transects the most 
anterolateral points of the lateral ventricles, ac-
cording to Waitzman et al. [1992]. The applied CT 
scan measurements, locating the frontal and pari-
etal bone centers in the horizontal plane, have 
previously been described and shown to be valid 
[Mathijssen et aI., 1996]. Briefly, the frontal and 
parietal bone centers, being the prominences or 
tubers of the respective bones, are identified by the 
sharpest angle of their bone on axial slices. The 
anteroposterior distance between this point and 
the most frontal point of the skull is measured, 
constituting the frontal (FBCD) and parietal bone 
center distances (PBCD), respectively. All mea-
surements were standardized with reference to the 
5-cm scale bar on each film. After obtaining the 
FBCD and PBCD, the !BCD was calculated by 
subtracting the FBCD from the PBCD. The mean, 
standard deviation, and 95% confidence interval 
were calculated for the IBCD (P = 0.05, two-
sided). The obtained data on IBCD were plotted 
against patients' age at the time of taking the CT 
scan. 
Application of this method for detection of the 
parietal bone centers in cases with sagittal suture 
synostosis was not undertaken for the following 
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TABLE 1. Distance between frontal and parietal bone centers, 
the interbone center distance (IBCD), taken on both sides of 
seven dry skulls of normal human fetuses ranging in age from 15 
to 23 weeks of gestation 
Age (weeks of gestation) IBCD right (mm) IBCD left (mm) 
15 16 t6.5 
16 22 20 
17 24 26 
18 29 28 
19 32 31.5 
21 42 38 
23 51 50.5 
reason. The sharpest angle of the parietal bones, 
i.e., the parietal bone centers, were found on the 
most cranial slices of these patients' CT scans. 
These slices obviously miss out the applied referR 
ence point, as mentioned above, to which the bone 
center distance is related. Furthermore, the quality 
of these last slices of the CT scan is often inferior. 
To -overcome these drawbacks, one should apply 
CT scans taken in the coronal plane, with an 
appropriate reference point. Data for a normal 
population should be gathered for comparison 
with the data for sagittal suture synostosis. HowR 
ever, these 2Rmm coronal CT scans are not availR 
able for either the normal population or 
scaphocephalic patients at present. 
Dry skulls. For comparison with the actual disR 
tance, as measured directly on the dry Apert 
skulls, the IBCD was also calculated, based 
upon the FBCD and PBCD taken from their CT 
scans. 
Results 
Dry skulls 
Table 1 outlines the data set on IBeD in relation 
to age during normal prenatal development. Dur-
ing undisturbed development of the cranium, the 
distance between the frontal and parietal bone 
centers increases with age because the coronal 
suture allows growth between these centers (Table 
2). The reported data could be somewhat underes-
timated, since some shrinkage of the specimens 
may have occurred, particularly in the younger 
specimens, in which there is still a membrane 
linking the bone plates. The older dry skulls had 
some degree of moulage, thus reducing the actual 
distance. At 16 weeks of gestation, the first onset 
of the coronal suture seen was situated exactly in 
line with the frontal and parietal bone centers 
(Fig, 1). Because it is at this locus that the distance 
for both bone plates to overcome is the least, it is 
no surprise that first contact, and thus suture 
initiation, is made here. Subsequently, the forma-
tion of the coronal suture progressed in both craR 
nial and caudal directions. At 18 weeks, the 
coronal suture appeared to have been established 
along its entire length, while the sagittal suture 
had just begun its development. Similarly, first 
onset of the metopic (15 weeks), lambdoid (16 
weeks), and sagittal sutures (18 weeks) were seen 
at the point where the suture crosses the line 
connecting both contributing bone centers. De-
spite a slight difference in age, the rBCD on both 
sides of the two neonatal Apert skulls measured 16 
mm. 
TABLE 2. Scattergram of interbone center distance (IBCD) in relation to age of human fetuses 
60 
50 
10 
t • 
• 
• 
age (weeks of gestation) 
• 
• 
• 
Due to growth with'ln the (Mure) coronal suture, the distance between the frontal and parietal bone center increases with age. 
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Perioperative 
Perioperatively, both parietal bone centers in 
scaphocephalic children were noticed to be situ~ 
ated near the median (Fig. 2), i.e., towards the 
synostotic sagittal suture. In other words, the pari~ 
etal bone centers were displaced upwards. In cases 
with coronal suture synostosis, the frontal and 
parietal bone centers were seen to be situated next 
to the synostotic suture. 
Computerized tomography scans 
Patients. The mean IBCD at the unaffected side of 
patients with a unilateral coronal suture synostosis 
(N ~ 18) was 79.6 mm (range 53.6-97.2 mm), with 
a standard deviation of 10.7 and a confidence of 
4.9 (P ~ 0.05). The average age of this subpopula. 
tion was 11 months. The scattergram of these data 
(Table 3) shows an increase in IBCD in relation to 
age, caused by growth of the skull at the coronal 
suture. 
In contrast, the mean IBCD for all the synos~ 
totic coronal sutures (N = 90) was 43.7 mm (range 
11.2-63.9 mm), with a standard deviation of 12.5 
and a confidence of 2.6 (P = 0.05). The age of the 
patients at the time of scanning ranged from less 
than 1 month to 4 years of age (average 8 
months). Indeed, no correlation was found be~ 
tween IBCD and age ( - 0.24), as is illustrated in 
Table 4. 
Correlating the synostotic IBCD to the normal 
IBCD in human fetuses places this congenital mal~ 
formation near the stage of 21 weeks of gestation. 
Just prior to this developmental stage, the coronal 
suture is normally formed. Therefore, it is not 
likely that in craniosynostosis the bone centers 
arise primarily on an abnormal position. This data 
analysis implies that the bone center displacement 
occurs secondary to the fusion of the bone plates. 
Dry skulls. The right~ and left-sided IBCD of the 
two Apert skulls, determined by CT scan measure-
ments, are 16.3 and 15.6, respectively, and 22.5 
and 16.3, respectively, closely approaching the ac~ 
tual distances of 16 mm. 
Discussion 
The fact that in coronal suture synostosis the 
frontal and parietal bone centers are located at a 
fairly constant, reduced distance from each other 
suggests that the initial development of the skull 
bones was undisturbed, allowing some degree of 
outgrowth. Bone center position is most accu-
rately determined by judging their position, based 
upon the radiating pattern. Therefore, the IBCD 
obtained by direct measurement on the patients' 
calvariae and dry skulls - which no longer have a 
membrane between the bones - are more realistic 
than those obtained from CT scans. In particular, 
with the bony tubers getting less prominent with 
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Fig. 1. Photograph in lateral view of 
dry skull of human fetus with an esti-
mated age of 16 weeks of gestation, 
comparable to the schematic illustra-
tion in Figure 3. Notice that the onset 
of the coronal suture is located where 
the line connecting the frontal and 
parictal bone centerS crosses the sutural 
area. 
Fig. 2. Perioperative view of a patient suffering from sagittal 
suture synostosis seen from above with the frontal bone at the 
top. Determined by the radiating pattern, both parietal bone 
centers (arrowheads) can be identified near the affected suture. 
age, the error in CT measurements of the bone 
centers will probably increase. But the trend of a 
constant value between the frontal and parietal 
bone centers irrespective of age, as shown by the 
CT measurements, does contribute to our follow-
ing hypotheses. With respect to the Apert dry 
skulls, coronal suture formation was prohibited 
and fusion took place at the time during embryo-
genesis when the distance between the frontal and 
parietal bone centers measured about 16 mm. 
From that moment on, growth of the fused frontal 
and parietal bone complex could only take place 
at the free margins, with the coronal suture miss-
ing. As a result of this growth, the observed mal-
position of the involved bone centers becomes 
relatively more severe in time (Fig. 3). The ob-
served range in IBCDs of the craniosynostotic 
patients could represent a slightly different timing 
of sutural closure in each individuaL Perhaps a 
certain IBCD can be related to a given genetic 
mutation. For this we need the most accurate data 
on IBCD and thus need to measure this distance 
during surgery, which is currently being under-
TABLE 3. Scattergram of interbone center distance (IBCD) at the 
unaffected side of patients with coronal suture synostosis in 
relation to age 
100 
• 90 ~ • 
80 
.-J :. • 
70 
e- 60 • S • 50 
" 0 40 !!! 30 
20 
10 
o+----+----+----+----+---~ 
o 10 20 30 40 50 
age (months) 
With age, the distance between the frontal and parietal bone 
centers increases due to grovvth at the coronal suture. 
taken at our department. Because normal develop-
ment of the sagittal suture occurs some stages later 
than that of the coronal suture, the sagittal suture 
synostosis will correspondingly arise later during 
embryogenesis. 
In our clinical practice, a limited number of 
patients, most often clinically diagnosed as Crou-
zon syndrome, present with a late (postnatal) on-
set of sutural closure. At first the sutures are open, 
but in time a progressive ossification is observed. 
We described nonnal bone center positions in all 
seven of these patients in our former paper 
[Mathijssen et a!., 1996]. Indeed, outgrowth of the 
individual bone plates was undisturbed up to the 
age of synostosis onset, and the sutures did have 
TABLE 4. Scattergram of interbone center distance (IBCD) in 
relation to age of patients suffering from coronal suture synosto-
sis, revealing no correlation between the two parameters . 
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Fig. 3. Schematic drawing of the normal human development 
of frontal and parietal bones and the coronal suture between 
(left), and the development of coronal suture synostosis with 
secondary bone center dispositioning (right). Embryogenesis is 
undisturbed until the age of 16 weeks of development. Bone 
centers arise in their normal position and grow out in a radial 
manner, approaching one another. At about 16 weeks, bony 
fusion takes place at the site where coronal suture formation 
was supposed to start off. From then on, the distance between 
the frontal and parietal bone centers is fixed, and growth only 
occurs at the free edges of the bone plates. With growth 
occurring, the bone centers appear more and more displaced 
toward the affected suture. 
the chance to develop. Because this onset is rela-
tively late, the bone centers have assumed a near 
normal position. So again, even in these cases, the 
IBCD can be directly related to the onset of suture 
closure. 
In this study, the same principle of malposition 
of bone centers toward the affected suture bas 
been established for sagittal suture synostosis, as 
was done earlier for metopic and coronal suture 
synostosis. This is in contrast to findings published 
earlier by Richtsmeier et al. [1998]. According to 
their findings, tracings of the parietal bone centers 
in sagittal suture synostosis were inferior com-
pared to normals. For their analysis, 3-D recon-
structions were used, on which an observer 
marked a prominence of each parietal bone sup-
posedly representing the parietal bone center. In 
our clinical experience, we find it hard to distin-
guish the parietal bone centers as being a promi-
nence in cases with sagittal suture synostosis, both 
during surgery and on CT scans, because they are 
located almost completely cranially next to the 
ridging sagittal suture. Therefore, their position 
can be most accurately determined, based on the 
radiating growth pattern, e.g., during surgery. 
We no longer consider the displacement of bone 
centers in craniosynostosis to be the causative 
factor. As demonstrated in a study on positional 
changes of the bone centers during embryogenesis 
of rabbits suffering from coronal suture synosto-
sis, frontal and parietal bone center positions for 
the wild type and affected animals were identical 
up until the time of synostosis onset [Dechant et 
aI., 1998, 1999; Mooney et aI., 1998]. From this 
stage on, the bone centers became displaced in the 
animals suffering from coronal suture synostosis. 
Having traced craniosynostosis to its developmen-
tal stage through bone center displacement, we 
have further substantiated the timing after which 
an ultrasound should be able to visualize this 
congenital malformation prenatally [Van Der 
Ham et aI.. 1995]. 
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Apoptotic Cell Death During Normal 
Embryogenesis of the Coronal Suture: 
Early Detection of Apoptosis in Mice 
Using Annexin V 
R. L. J. H. Bourez 
I. M. J. Mathijssen, MD 
J. M. Vaandrager, MD 
C. Vermeij-Keers, PhD, MD 
Rotterdam, The Netherlands 
Regulation of programmed cell death (apoptosis) is 
crucial for normal development and growth, both 
pienatallyand postnatally, If its role during norinal 
embryogenesis of a given structure is established, a 
number of related congenital disorders can be exw 
plained by a (local) deregulation of apoptosis. In 
this study, apoptotic cell death patterns during nor-
mal development of the murine coronal suture 
were investigated. Detection of apoptotic cells was 
undertaken by labeling with Annexin V. Results 
showed apoptosis accuning at the same time and 
place as suture initiation. Apoptotic cells are lo-
cated along the entire established part of the suture 
and its developing part. Because apoptosis is 
shown to be highly associated with sutural genesis, 
the theory of craniosynostosis being the equivalent 
of deregulation at this locus seems in line with 
these findings. 
Key Words: Apoptosis, Annexin V, suture, embryo-
genesis, craniosynostosis 
I n the extensive literature on sutural develop-ment and histology, few reports exist on the role of apoptotic (programmed) cell death. Yet apoptosis is known to be a crucial process in 
normal growth and development [I]. Apart from its 
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role in embryogenesis, apoptosis constitutes an im-
portant def~n.se mech~s~-_:against viral" infections 
,.and cancer .. Different kinds of diseases can be ex-
plained by a deregclation m' apoptotic cell death. In 
particular, the occurrence of a nwnber of congenital 
defects can be explained by a deficiency or an abun-
dance of apoptosis (e.g., syndactyly and cryptoph-
thalmos, respectively). To Wlderstand their patho-
embryogenesis, the exact role of apoptosis in normal 
embryogenesis needs to be established. 
Because apoptosis is considered to be involved 
in keeping cranial suhlres patent [2], craniosynosto-
sis (premature suture closure or sutural agenesis) 
seems to be the equivalent of a shortage of apoptosis 
at this specific point [3]. 
One of the first authors to report on the occur-
rence of cell death at the level of sutures was Ten 
Cate and others in 1977 [4]. They recognized cell 
death-taking place in the central area of the su-
ture-by characteristic morphological changes of the 
involved cells: shrinkage, nuclear condensation, and 
blebbing of cell membrane. This observation was 
made in the sutures of young rats at the ages of 1 and 
2 days postnatally. Beyond this age, cell death was 
no longer detected. No prenatal stages of develop-
ment were investigated. It was speculated that mes-
enchymal cell death in the suture separates the bones 
of the developing suture. In 1981, Albright and Byrd 
[5] postulated that craniosynostosis represents fail-
ure of calvarial bones to stop growing rather than 
premature closure of a suture, because normal suture 
closure never involves bony fusion. Furtw"angler and 
associates [6] considered the cause of craniosynosto-
sis to be explained by the failure of an undetermined 
mechanism that prevents contact and fusion of adja-
cent bone territories. In their study on sutural mor-
phogenesis in mice, they described a histological pic-
ture U strongly suggestive of a form of cell death 
called apoptosis," classifying cells as being apoptotic 
by their morphological changes, in accordance with 
Ten Cate and others [4]. Although mice ranging in 
age from 16 to 34 days postconception (PC) were 
used, apoptosis was only seen postnatally (22-26 
days PC). Apoptosis was described as occurring 
whenever the approaching bones of the involved su-
ture failed to overlap one another. As in the study by 
Ten Cate and colleagues [4], apoptosis was con-
cluded to be "a morphogenetic mechanism that may 
function in preventing physical contact and resultant 
fusion of adjacent mineralized zones_" 
During normal human development of the cal-
varia, the frontal and parietal bones are formed by 
ossification of the membranous anlagen. The starting 
points of bony deposition are called bone centers 
. (i.e., tubers). Ossification extends radially from these 
b'one centers toward the margins, with the bones ap-
proaching each other [7,8]. The position of sutures 
appears to be determined by the meeting of the 
bones [7,9]. Our previous study on the pathoem-
bryogenesis of craniosynostosis showed a disposi-
tioning of bone centers toward the synostotic suture 
in isolated coronal and metopic suture synostosis 
and in coronal suture synostosis in Apert's syn-
drome [10}. Sutural synostosis is known to start off at 
a specific locus from which fusion progresses along 
the suture [2, 5}. This locus was shown to be situated 
exactly between the two dispositioned bone centers 
[10]. On the basis of these observations, we postu-
lated that craniosynostosis is associated with a deficit 
of apoptosis at the site where the outgrowing, dis-
placed bone centers meet during embryogenesis. As 
a result, bony fusion (i.e., sutural agenesis) occurs 
locally and spreads from here across the suture. To 
substantiate this hypothesis in research, the apop-
totic patterns in suture formation during normal 
mammalian development need to be established. 
In our study, apoptotic cell death during murine 
embryogenesis was detected by labeling with An-
nexin V. In vivo, phosphatidylserine (PS) is ex-
pressed on the inner side of the plasma membrane in 
virtually all cell types [11]. In the early stages of ap-
optosis, PS is translocated to the outer layer of the 
membrane (i.e., the external surface of the cell), while 
the cell maintains its membrane integrity. The ex-
posed PS mediates recognition and uptake by phago-
cytes [12]. Because Annexin V is a Ca2+ -dependent 
phospholipid-binding protein with a high affinity for 
PS [13], this protein can be used for detection of PS 
exposure (i.e., cells in early to late phases of apopto-
sis) [11]. This technique was applied to study apop-
tosis in the normal development of cranial sutures, 
namely the coronal suture. 
MATERIALS AND METHODS 
For this study, the FVB mouse was used. Accord-ing to Theiler's calculation [14], the morning after 
mating (determined by the presence of a vaginal 
plug) was called day O. The mouse was killed by 
cervical dislocation after sedation using ether inha-
lation. The uterus was extirpated, and the extra em-
bryonic membranes were removed. A total of 77 FVB 
mouse embryos (prenatal) and fetuses (postnatal), 
ranging in age from 13 to 25 days PC, were collected 
(Table 1). 
Macroscopic Investigations 
Whole embryos and fetuses of the different ages 
were stained for cartilage and bone (n = 19) using 
aldan blue 8GX (Sigma A 3157) and alizarin red 
(Sigma A 5533). 
Microscopic Investigations 
For apoptosis detection, specimens were injected 
with Annexin V Biotin (A V-B,500 ILg/ml; APOPTEST-
Number of Murine Embryos and Fetuses for Each 
Given Age Used for Bone and CartHage Staining, 
Apoptosis Detection, I njected Controls, and 
Noninjected Controls 
Age" AlB/AIR hrh AV-Bhr' AV·XB hfl Controls" Total 
13 
13.5 
,. 
14.5 
15 
16 
17 
17.5 
18 
19 
20 
21 
22 
23 
2. 
25 
Total 
1 
6 
"Days postconception. 
bAlcian Blue/Alizarin Red. 
2' 
1 
2' 
1 
3 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
cAnnexin V Biotin. 
dHeat-inactivated Annexin V Biotin. 
eNoninjected. 
'Injected intracardial. 
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biotin kit, NeXins Research BV, The Netherlands) us-
ing a Hamilton-Syringe pipetting system with glass 
needles (25-50 ~m in diameter). A few of the young-
est embryos were injected intracardially, which re-
sults in distribution of AV-B throughout the body 
(see Table 1). A survival period of the specimens of 
approximately 30 minutes culture is required for this 
technique. The older animals were injected subcuta-
neously eSC) at the site of the (future) coronal suture: 
embryos aged up to 16 days PC were injected SC 
with 0.5 to 1.0 ~l; embryos of 17 days PC and older 
were injected SC with 1.0 to 2.0 1).,1. Before injection, 
ether sedation was administered to the viable speci-
mens. Several embryos and fetuses were accordingly 
injected with heat-inactivated AV-B (AV-XB, 10 min-
utes at 56°C) to serve as a control for aspecific bind-
ing of Annexin V [15]. Furthermore, controls for each 
given age that were not given any injection were 
obtained. Apoptosis detection for these two control 
groups was based on changes in cellular morphol-
ogy, typical for apoptosis. 
The embryos of 13.5 to 16 days PC were col-
lected in a Hepes solution (7.72 gm sodium chloride, 
0.45 gm potassium chloride, 0.28 gm calcium chlo-
ride, 0.25 gm magnesium sulfate, 0.21 gm K2HPO, (potassium monohydrogen phosphate), 0.99 gm glu-
cose, 4.77 gm Hepes, 5.0 gm bovine serum albumin 
in 1 L AquaDest, pH 7.0-7.4) at 35 to 36"C. Older 
animals (> 17 days PC) were kept at room tempera-
ture. After 30 to 60 minutes of survival, the speci-
mens were killed by decapitation. To increase time of 
survival by stimulation of breathing, the umbilical 
cord of embryos at the age of 17 days PC were li-
gated. All subjects beyond the age of 14 days PC 
were decalcified with disodium ethylenediamine-
letraacetic acid salt (Sigma ED2SS) for 4 days, pro-
cessed for paraffin embedding, and serially sectioned 
in the sagittal plane at 5 to 20 iJ-m. The sections were 
mounted on slides, previously coated with 2% 3-
aminopropyltriethoxysilane to prevent background 
staining. Bound A V·B was visualized using the avi-
din-biotin complex method with horseradish perm<i-
dase-conjugated avidin. After washing with phos-
phate-buffered saline (PBS), staining was developed 
with 3,3' -diaminobenzidine tetrahydrochloride and 
counterstained with hematoxylin. The sections were 
examined light microscopically. 
RESULTS 
Macroscopic Investigations 
Bone and cartilage staining revealed the appear-ance of frontal and parietal bone centers in the 
membranous anlagen at the age of 13 and 14 days, 
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respectively. Bone formation spreads radially from 
these centers on, with the skull bones approaching 
each other. At the age of 16 days PC at the most 
lateral site of the skull, the frontal and parietal bones 
meet first initiating the coronal suture fonnations. 
Suture development progresses from here on both 
cranially and caudally. 
Microscopic Investigations 
Apoptotic cell death is first noticed at the age of 16 
days PC at the most lateral site of the skull (Fig lA). 
Its distribution exceeds the zone of suture initiation 
(Fig IB) in both the cranial and caudal directions. 
One day later (17 days PC), the number of labeled 
cells has increased. Apoptotic cells are distributed 
alongside the established and developing part of the 
suture and the adjacent area where the outgrowing 
bones have not met yet. At the age of 18 days PC, 
coronal suture formation is complete, with apoptotic 
cells lining its entire span. 
Until 18 days Pc. the frontal and parietal bones 
were lying within the same dorsoventral plane, but 
they now start to overlap. The frontal bone overlaps 
the parietal bone at the lateral side of the skull, and 
medial to this locus the parietal bone overlaps the 
frontal bone (Fig lC). At this transition, the edge of 
the frontal bone starts to splice. Because of the over-
lap, there seem to be two sutural areas betvveen the 
frontal and parietal bones within one plane (see Fig 
lC). 
In time, the splicing of the frontal bone is ex-
tended, with apoptotic cells located between its WO 
layers (Fig ID). With the increasing degree of overlap 
in consecutive stages, the observation of two sutural 
areas in one plane becomes more evident. In both 
sutural areas apoptotic cells were found (Fig 1E). 
The number of apoptotic cells, determined serni-
quantitatively, increases during the subsequent de-
velopmental stages, until the age of 23 days PC, 
when the number declines. The number of apoptotic 
cells in the animals injected with AV-XB and in the 
noninjected animals, detected by their morphological 
appearance only, was much less. 
DISCUSSION 
Craniosynostosis is said to result from a deregu~ lated coordination between osteoblastic differen-
tiation within the suture and subsequent bone depo-
sition on one hand and skull growth and timing of 
suture closure on the other hand [16]. We consider 
apoptosis, occurring time and place dependent to be 
one of the processes essential in maintaining this bal-
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Fig 1 All photographs concern sagittal sections with the fetus or embryo facing the right. (A) First occurrence of apoptotic 
cells (arrow) at the site of coronal suture initiation. F '" frontal bone; P = parietal bone (16 days postconception [PCI. 
Annexin V, avidin-horseradish peroxidase (HRPl-diaminobenzidine tetrahydroch1oride (DAB), and hematoxylin. original 
magnification )( 20). (8) Apoptotic ceil (arrow) in the area just caudal to the zone of suture initiation. F = frontal bone; P 
= parietal bone (16 days PC, Annexin V, avidin-HRP-DAB, and hematoxylin, original magnification x 20). (C) The parietal 
bone {P} overlaps the frontal bone (F), giving rise to two sutural areas within one plane (arrowheads) (1S days PC, Annexin 
V, avidin-HRP-DAB, and hematoxylin, original magnification x 10). (D) The frontal bone is spliced into an inner (Fi) and 
an outer (Fa) layer, with apoptotic cells located in between. P = parietal bone (22 days pc, Annexin V, avidin-HRP-DAB, 
and hematoxylin. original magnification x 10). (E) Apoptotic cells located in both sutural areas (arrowheads). Fi:o inner layer 
of frontal bone; Fo :0 outer layer of frontal bone; P :0 parietal bone (23 days pc, Annexin V, avidin-HRP-DAB, and 
hematoxylin, original magnification )( 10). 
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ance during normal development. The study pre-
sented here demonstrates that apoptosis takes place 
at the site of coronal suhue initiation, even before 
actual formation, indicating that apoptosis is highly 
associated with suture development. So far, apop-
totic cell death was believed to occur in cranial su-
tures postnatally only [4, 6]. It seems justified to state 
that apoptosis is involved in establishing sutures as 
well as keeping them patent. These results imply that 
lack of apoptosis at this site could result in cranio-
synostosis. Because suture formation does OCCUf in 
craniosynostosis, namely cranial and caudal to the 
fused bone centers [10], it is to be expected that ap-
optosis initially takes place at these locations. In time, 
the process of programmed cell death seems to be 
overruled by the stimulus to ossify, originating from 
the fused bone centers. 
The complete cascade leading to apoptosis and 
the triggers for its pathways are not fully mapped 
[17]. Albright and Byrd [5] suggested contact of the 
outgrowing bones and skull molding during deliv-
ery to be such triggers. They substantiated this 
theory by remarking that apoptosis was only seen 
postnatally. With our ability to detect cells in the 
early and late stages of apoptosis using Annexin V, 
we demonstrated it to also take place prenatally, at 
the time of first suture initiation. This excludes the 
suggested triggers but does not indicate which fac-
tors are involved. 
Because mutations in fibroblastic growth factor 
receptor (FGFR) genes in craniosynostosis syn-
dromes [18-20] have been discovered, perhaps the 
apoptotic cascade is influenced by their products. 
Apoptosis could be one of the processes linking the 
genetic defect to the resulting morphological appear-
ance. Isolated craniosynostosis seems to result from 
the same local disturbance of regulation of apoptotic 
cell death, because it has been shown to involve dis-
positioned bone centers similar to that in Aper!' s 
syndrome [10]. However, no mutations in the FGFRs 
have been described in the isolated types to date. 
Apparently, in isolated craniosynostosis another 
pathway is disturbed, meeting the syndromic ones at 
the end of the road, namely inhibition of apoptosis. 
This work was supported in part by Dutch Association for Scien-
tific Research AGIKO Grant AGI 920-03-011. 
Part of the results of this study were presented at the Dutch As-
sociation for Anatomists, Lunteren, The Netherlands, January 4, 
1997, and at the 8th European Association of Plastic Surgeons 
Meeting, Amsterdam, May 15, 1997. 
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Simultaneous induction of apoptosis, collagen type I expression 
and mineralization in the developing coronal suture following 
FGF4 and FGF2 application. 
LM.J. Mathijssen\ J.P.T.M. van Leeuwen2, Chr. Vermeij-Keers l 
I Institute of Plastic Surgery at the Erasmus University Rotterdam and 
2Department of Internal Medicine III at the University Hospital 
Rotterdam, The Netherlands 
Abstract 
This study aimed at evaluating the disturbances in normal coronal 
suture development resulting in craniosynostosis, a congenital 
disorder in which the calvarial sutures close prematurely. 
Craniosynostosis syndromes can be caused by mutations in the genes 
encoding for the fibroblast growth factor receptors (FGFR) 1,2, and 3. 
These gain-of-function mutations cause the transcribed receptor to be 
constitutively activated. To mimic this genetic defect fibroblast 
growth factor (FGF) 2 or 4, with a high affinity for FGFR2, was 
administered near the developing coronal suture in normal mouse 
embryos through ex utero surgery. The effect on apoptosis and bone 
differentiation, as collagen type I expression and mineralization, 
within the FGF-exposed coronal suture was investigated through 
(immuno )histochemical staining. An increase in the number of 
apoptotic cells together with ectopic collagen type I expression within 
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the suture and accelerated mineralization followed fibroblast growth 
factor application. Macroscopically this presented as a synostotic 
coronal suture. These results suggest that both apoptosis and 
differentiation are two processes that are simultaneously implicated in 
synostosis of the coronal suture in case of a fibroblast growth factor 
receptor-related craniosynostosis. 
Introduction 
Growth ofthe skull normally occurs at the site of the calvarial sutures. 
Craniosynostosis is a congenital malformation in which one or more 
calvarial sutures have fused prematurely (most often prenatally) or 
haven't been established at all, arising in approximately I in 2,500 
live births. Skull development is restricted and as a result the head 
shape becomes distorted. This condition may be associated with 
additional abnormalities, mostly involving the limbs, thus constituting 
a craniosynostosis syndrome. In approximately 50% of the syndromic 
cases mutations in fibroblast growth factor receptor (FGFR) I, 2 or 3 
genes or TWIST gene can be detected (Wilkie, 1997). A mutual 
feature of patients with a craniosynostosis syndrome is synostosis of 
one or both coronal sutures. With respect to most FGFR2 mutations 
causmg craniosynostosis, the transcribed receptor itself is 
constitutively activated, independent of the presence of its FGF 
ligands (Neilson and Friesel, 1995; Neilson and Friesel, 1996; Galvin 
et aI., 1996; Mangasarian et aI., 1997; Robertson et aI., 1998). So far, 
only the FGFR2 mutations Ser252Trp and Pro253Arg causing Apert 
syndrome have been found to be dependent on the availability of 
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FGF2 for which the mutant receptors have a lowered dissociation rate, 
promoting increased signalling activity (Anderson et aI., 1998). 
The craniosynostosis syndromes have highlighted the importance of 
FGFRs in craniofacial development and in particular the cranial 
sutures. Iseki and coauthors studied the expression and function of 
FGFRI and FGFR2 during skull development. They found FGFR2 to 
be expressed by proliferating osteogenic precursor cells, situated at the 
extensions of the frontal and parietal bones (Iseki et aI., 1997). Closer 
to the osteogenic fronts of the frontal and parietal bones, FGFR2 
expression was down-regulated and FGFRI expression up-regulated, 
preceding the onset of bone differentiation. Signalling through FGFRI 
was shown to regulate osteogenic differentiation whereas signalling 
through FGFR2 regulates proliferation. One of the local factors that 
seemed to have a modulating fuuction in keeping this balance was 
fibroblast growth factor 2 (FGF2) (Iseki et aI., 1997; Kim et aI., 1998). 
Within the center of the suture FGF2 was hardly detectable, while its 
concentration rose towards the osteogenic fronts, being highest in the 
osteoid (Iseki et aI., 1997). In general, the pattern of FGF2 distribution 
was the reverse of that for FGFR2. Whilst this provides some insight 
into the mechanism for normal calvarial development it remains 
uncertain how these processes are affected by mutated FGFRs. 
It has been suggested that apoptosis, i.e., progrannned cell death, is 
important in the pathogenesis of skeletal disorders and in particular 
craniosynostosis (Bourez et aI., 1997; Hughes and Boyce, 1997; Rice, 
Kim and Thesleff, 1999). Likewise, derangement in the extent of 
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apoptosis has been associated with numerous other congenital 
malformations, for example complete cleft lip/alveolus/palate 
(Vermeij-Keers et aI., 1983) and interdigital webbing (Van Der 
Hoeven et aI., 1994). In normal adult human bone a number of 
differentiating bone cells appear to be lost via apoptosis (Parfitt, 1994; 
McCabe et aI., 1995). In the developing coronal suture of mouse 
embryos, apoptotic cells have been located exclusively near to the 
osteogenic fronts of the frontal and parietal bones (Bourez et aI., 1997; 
Rice, Kim and Thesleff, 1999). 
The main purpose of this study was to assess changes in apoptosis and 
osteoblast differentiation during embryogenesis in FGFR2-related 
craniosynostosis. In the absence of an animal model for FGFR 
mutation-mediated craniosynostosis, injection ofFGF2 or FGF4 in the 
vicinity of the coronal suture in mouse embryos has been used to 
mimic increased FGFR2 signalling. Initially, FGF4 was chosen 
because of its high affmity for FGFR2 (Goldfarb, 1996) and 
additionally FGF2 was used because of its natural occurrence in the 
developing skull. Analysis of this model involves immunohistological 
localization of apoptosis and bone differentiation through collagen 
type I production and mineralization. 
Materials and methods 
Animal model 
For this study, the F.V.B. mouse was used. EO was determined as the 
morning after mating (presence of a vaginal plug). Embryos ranging 
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in age from E 14 to E 18 at the time of surgery were included in this 
study, with a total number of 106 specimens (table I). 
Aliz. V. Kossa ColI. Annex. Tunel double 
Red type I labeling 
EI4/FGF4124h 6 
EI5/FGF4124h 7 
EI5/FGF4/48h 9 
EI6IFGF4124h 10 
EI7/FGF417.5h 2 4 
EI7/FGF4110h 2 2 
EI7/FGF4/24h 20 3 3 10 3 2 
EI7/FGF2/24h I 3 6 
E171X-FGF4124h 2 2 
EI7/PBS124h 2 3 
EI8/FGF4/24h 4 
TOTAL (106) 33 6 3 59 3 2 
Table I. Number of examined specimens for age, treatment, survival 
period and staining method. 
Development of the coronal suture was initiated at the age of E 16 and 
was complete at E18 (Bourez et aI., 1997). Surgery on pregnant mice 
of the required age was undertaken after applying general anesthesia 
through inhalation (Halothane/02INzO). The uterus and embryos were 
exposed via a median abdominal incision and approximately 1.0 f!l 
FGF2 (human recombinant basic FGF, Sigma-Aldrich Chemie BV, 
Zwijndrecht, The Netherlands) or FGF4 (human recombinant FGF4, 
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Sigma-Aldrich Chemie BV, Zwijndrecht, The Netherlands) from 
stocks of 10 /lg/ml or 100 /lg/ml respectively in PBS, was injected 
unilaterally using a pressure injector (1 bar) and a glass needle 
(diameter 25-30 /lm) near the (presumptive) coronal suture of the 
embryos. The contralateral untreated coronal suture within the same 
specimen was used as control. Also, a control group was injected 
similarly with either heat inactivated FGF4 (X-FGF4, 10 minutes at 
56°C) or PBS only. After the injections were administered the uterus 
wall was partially incised to prevent premature delivery, leaving the 
embryonic membranes intact. The uterus was then repositioned into 
the abdomen and the abdominal wall was closed in layers. 
Detection of apoptosis 
After periods ranging from 7.5 hours up to 48 hours post injection 
(Pj.) the mouse was sacrificed and all viable embryos were removed 
from the uterus and kept at 37° C. The applied marker for apoptosis 
was Aunexin V-biotin (APOPTEST™-biotin kit 500 /lg/ml, NeXins 
Research BV, Maastricht, The Netherlands). This is an in vivo marker 
of the early phase of apoptosis onwards, which binds to 
phosphatidylserine (PS) (Van Den Eijnde et aI., 1997a). Aunexin V 
was injected subcutanously near to both coronal sutures and the 
animals were decapitated 30 minutes later. Specimens were fixed 
overnight in a 4% formaldehyde solution, decalcified with EDTA 
(Sigma-Aldrich Chemie BV, Zwijndrecht, The Netherlands), 
processed for paraffin embedding, and serially sectioned in the 
transversel or occasionally the parasagittal plane at 5-7 )lm. Sections 
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were mounted on slides, previously coated with 2% 3-
aminopropyltriethoxysilane to prevent background staining. Bound 
Annexin V -biotin was visualized using the avidin-biotin complex 
method with horse-radish peroxidase conjugated avidin and DAB, 
counterstained with the PAS-reaction (Schiff-reagent) and 
haematoxylin. 
A few exceptions are known of cells that label Annexin V because of 
PS presentation without being apoptotic (Van Den Eijnde et a!., 
1997a). These exceptions concern the megakaryoblasts and 
megakaryocytes at the time of formation of and disintegration into 
blood platelets, and myotubules during their cell fusion process. To 
ascertain the fact that the Annexin labeled cells within the suture are 
indeed apoptotic, additional Tunel staining (Boehringer Ingelheim 
BV, Alkmaar, The Netherlands) was performed. Tunel staining 
detects DNA cleavage sites and only marks cells in the late phase of 
apoptosis in contrast to Annexin V, as shown previously by double 
labeling experiments (Van Den Eijnde et a!., 1997b). In situ cell death 
detection was performed by applying the Tunel reaction mixture 
(deoxynucleotidyl transferase and nucleotide mixture), visualized with 
Converter-POD (anti-fluorescein antibody conjugated with horse-
radish peroxidase) and DAB, counterstained with Schiff-reagent and 
haematoxylin. 
Collagen type I expression and mineralization 
Anti -collagen type I immunohistochemical staining was performed on 
E17 embryos 24 hours after FGF administration to identify the 
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ongoing differentiation of cells within the coronal suture. Collagen 
type I is an early major component of osteoid. It is produced by 
osteoblasts during bone development (Aubin and Liu, 1996), and 
fundamental to the formation of mineralized matrix (Lynch et aI., 
1995). Sections for immunohistochemical staining with monoclonal 
anti-collagen type I (Sigma-Aldrich Chemie BV, Zwijndrecht, The 
Netherlands) were pretreated with pronase for 10 minutes and stained 
using a primary antibody titer of 1:2,000. Counterstaining was 
identical to that for Annexin. 
Double labeling for apoptosis and collagen type I was performed on 
FGF4 treated embryos, after 24 hours of survival. This was performed 
by injecting Annexin V-FITC near the coronal sutures in the embryos 
prior to decapitation. The aim here was to determine whether or not 
the Annexin V labeled (apoptotic) cells and the collagen type I labeled 
cells belonged to two separate cell populations. Sections obtained 
from these specimens were stained immunohistochemically with the 
previously described anti-collagen type I antibody and visualized with 
a second antibody labeled with TRITC. Specimens were viewed using 
a fluorescence microscope and photographed. 
Identification of mineralization sites was carried out using the Von 
Kossa method (2% Silver nitrate for 60 minutes in broad daylight), 
according to Bancroft and Cook (Bancroft and Cook, 1984), on 
sections of EI7 embryos treated with FGF for 24 hours. In addition, 
EI7 skulls were stained in toto for calcification to detect macroscopic 
changes of the coronal suture. Following removal of the skin and 
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treatment with a solution of alcohol, acetic acid and H20 2 to 
decolourize, the tissues was macerated with a 1% KOH-solution and 
stained with Alizarin Red. 
All illustrated sections were taken at an identical site of the cranial 
part of the suture (fig. I). Within a single specimen, the FGF-injected 
side was compared with the equivalent part of the non-injected suture. 
Differences between the FGF -treated suture and the age-matched X-
FGF4 or PBS-injected controls were determined semi-quantitatively 
through comparison of the number of labeled cells in representative 
sections and through analysis of the distribution of this labeling. For a 
representative FGF4 exposed EI7 suture the number of Annexin V 
labelled cells 24 hours pj. was determined for each individual section 
including the control suture. In order to estimate the length of the 
suture that was affected by the FGF exposure the number of sections 
with an altered structure was determined for different developmental 
stages and variable FGF-exposure time. 
Figure I. Schematic drawing of an EI7 mouse head showing the level 
of sectioning. The coronal suture is situated between the frontal (f) 
and parietal (P) bone. 
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Results 
Apoptosis 
An increased number of Annexin labeled cells within the FGF4-
exposed suture of E17 embryos compared to controls were found as 
early as seven and a half hours after the injection (fig. 2B and compare 
with fig. 2A). These apoptotic cells were situated at the extensions of 
the frontal and parietal bones, while at the control side only a few 
apoptotic cells could be traced exclusively near the osteogenic fronts. 
This increase in apoptosis was even more overt twenty-four hours 
after injection with FGF4 (fig. 2D and compare with fig. 2C). The 
labeled cells at this stage covered the entire sutural area transverselly 
from the edge of the frontal bone to the edge of the parietal bone, and 
also involved a more extended part of the length of the suture. Table II 
illustrates the number of Annexin V labelled cells in each consecutive 
section of a treated and its contralateral control suture of an E17 
embryo 24 hours pj. In the FGF-exposed suture a mean number of 7 
Annexin V labeled cells per section (range 2-18) was detected, while 
contralaterally this number was I (range 0-4). 
The FGF-treated suture ofE15 embryos showed numerous apoptotic 
cells near the osteogenic fronts, while labeled cells lining the 
osteogenic fronts of non-injected sutures at twenty-four hours p.i. 
were seen only occasionally (data not shown). In contrast to the E17 
and El8 injected sutures, the center of the suture remained free of 
apoptotic cells. No increase in apoptotic cells was seen within the 
sutural area of treated E 14 embryos, which were allowed to develop 
into the E IS stage. 
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Table II. Number of apoptotic cells within the treated and untreated 
coronal suture of an El7 embryo 24 hours pj., determined for 
consecutive sections of the affected area and the matching 
contralateral area. 
Normally, apoptosis at the sutural site is first detected at El6 with one 
or two apoptotic cells lining the frontal and parietal osteogenic fronts 
along a very limited segment of the established suture (Bourez et al., 
1997). Apparently FGF application did not advance the onset of 
apoptosis since no changes were seen in the pre-apoptotic stages (i.e. 
E 14). The length of affected suture increased with the age of the 
embryo at the time of injection and with the allotted survival time 
(table III). 
Similar induction of apoptosis followed injection with both 10 Ilg/ml 
and 100 Ilg/ml, though the length of altered suture was shorter with 10 
Ilg/ml treatment (259 Ilm compared to 686 Ilm for E17, 24 hours p.i.). 
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Table III. Scattergram of the sutural length (in 11m) along which an 
increased number of Annexin positive cells were detected in relation 
to age of the embryo and allotted survival time. 
Although both FGFs induced an increase in apoptosis this increase 
was greater with FGF4 than with FGF2 (fig. 2D compare with fig. 
2E). Following FGF exposure, there was an increase in the number of 
apoptotic cells throughout the sutural area, and apoptosis occurred 
along a more extended part of the suture. 
The findings in sutures injected with X-FGF4 or PBS were 
comparable to the normal unaffected pattern of apoptosis in the 
uninjected control sides ofthe FGF-treated animals (fig. 2A,C). 
Tunel staining revealed a similar distribution pattern of apoptotic cells 
within the control and injected sutures, substantiating the fact that the 
Annexin labeled cells are indeed apoptotic. As to be expected, the 
number of labeled cells with Tunel was lower than with Annexin V 
(fig. 3A,B) (Van Den Eijnde et aI., 1997b). 
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Collagen type I expression and mineralization 
At the control side, collagen type I was found within the frontal and 
parietal bones with no staining in the coronal suture area (fig. 4A). In 
contrast, collagen type I expression at the injected side was also found 
within the suture, along a track corresponding to that of the induced 
apoptosis (fig. 4B). This finding indicates the presence of collagen 
type I producing osteoblasts which are probably adjacent to the 
apoptotic cells. This was confirmed by double labeling with Annexin-
FITC and anti-collagen type I-TRITC which showed apoptotic cells 
and collagen type I -producing cells to be two separate, but co-
distributed cell populations, showing no overlap in expression (fig. 5). 
At the treated side Von Kossa method demonstrated mineralization of 
both the frontal and parietal bones with intense staining peripherally, 
including their osteogenic fronts (fig. 6D-G). In contrast, these parts 
of the bone plates showed hardly any staining at the control side, i.e., 
there was little mineralization (fig. 6A-C). Furthermore, at the injected 
suture the frontal and parietal osteogenic fronts were closer to each 
other in comparison with the control side (fig. 6D-G and compare with 
fig. 6A-C respectively), whilst thickness of the frontal and parietal 
bones appeared to have increased by FGF treatment. Alizarin Red 
staining of the complete skulls identified enhanced mineralization of 
the coronal suture in El7 and E18 embryos following FGF4 injection 
24 hours (fig. 7B) pj. This was only seen 24 hours pj. while the 
specimens of 7.5 or 10 hours pj. were comparable to the controls. In 
addition, heat-inactivated FGF4 or PBS injected controls did not differ 
microscopically nor macroscopically from untreated controls. 
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Figure 2. Apoptotic cell pattern in the control and FGF-treated coronal 
sutures visualized with Annexin V. 
Sections through the coronal sutures of E 17 specimens, control side 
(left column), injected side with FGF4 or FGF2 (right column), after a 
variable survival time. Magnification 400x. F = frontal bone plate, P = 
parietal bone plate, S = skin, M = myotubuli. 
A,B. Parasagittal sections through the coronal sutures of a E 17 
embryo, injected with FGF4 unilaterally, survival time 7.5 hours. 
A) The control suture demonstrates a limited number of brown-stained 
apoptotic cells (arrowhead), situated in the vicinity of the frontal 
osteogenic front. 
B) The suture exposed to FGF4 contains an increased number of 
Annexin labeled apoptotic cells, extending from the bony rims 
towards the sutural area, while the osteogenic fronts are in a near to 
normal position. 
C,D. Transversel sections through the coronal sutures of E17 embryos, 
injected with FGF4 unilaterally, survival time 24 hours. 
C) Apoptotic cells at the uninjected, control side are exclusively 
located near the rims of the bone plates. The line of Annexin labeled 
cells above the suture (M) are fusing myotubuli, known to bind 
Annexin V because ofPS exposure, without being apoptotic. 
D) Following FGF4 exposure, a large number of apoptotic cells are 
situated throughout the injected suture, combined with an advanced 
approximation of the osteogenic fronts. 
E) Transversel section through the coronal sutures of an E 17 embryo, 
injected with FGF2, survival time 24 hours. Apoptotic cells cover the 
entire suture, from frontal to parietal osteogenic front. The number of 
labeled cells is however smaller in comparison to the FGF 4 treated 
suture (Fig. 2D). 
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Figure 3. Apoptotic cell pattern in the control and FGF-treated coronal 
sutures visualized with Tunel. 
Transversel sections through the coronal sutures of an E 17 embryo, 
injected with FGF4 unilaterally, survival time 24 hours. A. control 
side; B. injected side. Magnification 400x. F = frontal bone, P = 
parietal bone, C = cartilage. 
A,B) Tunel staining matches the distribution of brown-stained 
apoptotic cells as detected with Annexin V for both the control side 
and the FGF exposed suture (compare Fig. 2C, D respectively). A 
lesser number of cells is labeled due to the fact that Annexin V also 
labels apoptotic cells in the early phases of apoptosis. 
Figure 4. Collagen type I expression in the control and FGF-treated 
coronal sutures. 
Transversel sections through the coronal sutures of a E17 specimen, 
injected with FGF4 unilaterally and surviving for 24 hours. 
Magnification 400x. F = frontal bone plate, P = parietal bone plate, C 
= cartilage. 
A) Control side. Labeled cells, indicating the presence of collagen 
type I producing osteoblasts, are normally lining the bone plates, 
leaving the sutural area free. 
B) Injected side. In the FGF-treated suture, collagen type I expression 
is also found within the suture, indicating the advanced differentiation 
at this site. 
Figure 5. Distribution of apoptosis and collagen type I expression in a 
FGF-treated coronal suture. 
Transversel sections through the coronal sutures of a E 17 specimen, 
injected with FGF4 after 24 hours of survival. Double labeling with 
Annexin V-FITC (green) and anti-collagen type I-TRlTC (red). 
Magnification 400x. F = frontal bone plate, P = parietal bone plate, S 
= skin. Orientation matches that of figures 2 to 4. At the left top, 
intense staining for collagen type I marks the skin (S) overlying the 
coronal suture. The staining for apoptosis and collagen type I within 
the suture is not overlapping, showing both cell types to be two 
different cell populations. 
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Figure 6. Mineralization in the control and FGF-treated coronal 
sutures. 
Transversel sections through the coronal sutures of a El7 specimen, 
control side (A,B,C), injected with FGF4 (D,E) or FGF2 (F,G), 
surviving for 24 hours. Detection of mineralization with the Von 
Kossa method. Right column shows details of pictures in left column 
at higher magnification. Magnification left column 200x; right column 
400x. F = frontal bone plate, P = parietal bone plate, S = skin. 
A) Overview of the coronal suture at the control side. No 
mineralization is detected at the peripheral parts or at the osteogenic 
fronts of the frontal or parietal bones. 
B) Same suture as is depicted in A, showing mineralization of the 
frontal bone at the control side only involving the central part 
(arrowhead indicates the border between mineralized and 
unmineralized bone). 
C) Coronal suture at the control side at higher magnification, again 
showing no signs of mineralization of the osteogenic fronts. 
D,E) Following FGF4 exposure, the mineralization of the frontal and 
parietal bones has extended peripherally, including the entire 
osteogenic fronts. Furthermore, these osteogenic fronts are in closer 
approximation, as compared to normal (A,B,C). The bone plates 
themselves appear to have an increased thickness. 
F,G) After FGF2 injection, comparable effects as for FGF4 are 
obtained with respect to enhanced mineralization. 
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Figure 7. Mineralization of the skull after unilateral injection with 
FGF near the coronal suture. 
Detection of mineralization with Alizarin Red staining of a skull of a 
E 17 specimen, injected with FGF4 and surviving 24 hours. 
A. Control side. Between the frontal (F) and parietal (P) bone plates, 
the coronal suture is seen as a mineralization-free line. 
B. Injected side. Twenty four hours after FGF injection, enhanced 
mineralization of the coronal suture can be seen. 
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Discussion 
The present study has clearly shown that exposure of the developing 
coronal suture to FGF4 or FGF2 enhances the entire developmental 
process from osteogenic precursor cell to mature osteoblast, as 
demonstrated by collagen type I expression, advanced mineralization 
and increased apoptosis. Both FGF4 and FGF2 are known to bind to 
FGFR2 (Omitz et a!., 1996), although FGF4 has a higher affinity 
(Goldfarb, 1996) and this could explain the stronger effect of FGF4 in 
this study compared to FGF2. The effect of FGF4 on apoptosis has 
been shown to be dependent of the embronic stage at the time of 
injection, exposure time, and FGF -concentration. 
The fact that apoptotic cells and collagen type I producing cells were 
situated throughout the suture following FGF injection suggests that 
precursor cells at various differential stages, i.e. preosteoblasts, 
osteogenic precursor cells and perhaps poorly committed stem cells, 
were involved. Since apoptotic and collagen type I expressing cells 
were two different co-distributed populations that appeared 
simultaneously, it is hypothesized that both the apoptotic and collagen 
type I expressing cells are the product of the final cell division of 
osteogenic cells. This has been reported in osteogenic differentiation 
of chondrocytes and referred to as 'asymmetric cell division' (26). 
This theory, however, needs further investigation. 
It appears that the increase in apoptosis precedes enhanced 
mineralization, given the finding that 7.5 and 10 hours post injection 
there was an increased number of apoptotic cells but no detectable 
change in the extent of mineralization. 
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Extrapolating these findings to the clinical problem the following 
concept is proposed. During embryogenesis of the cranial vault the 
FGFR2 gene is expressed by proliferating osteogenic precursor cells 
within coronal sutures which offer growth potential to the skull. 
Normally, a balance is kept between the degree of proliferation, 
differentiation, and apoptosis of osteogenic (precursor) cells. 
Apoptosis seems to be key in this respect first by limiting both the 
number of osteoblasts (Parfitt, 1994) and their precursors (Rice, Kim 
and Thesleff, 1999) which become differentiated osteocytes and 
second by contributing to mineralization of the osteoid (Lynch et aI., 
1998), supposedly by releasing previously stored huge amounts of 
calcium (Zimmermann, 1992). Apoptosis in bone tissue has been 
previously reported at the sites of osteogenesis, both during bone 
development and fracture repair, supporting the hypothesis that 
apoptosis is functionally related to mineralization (Ferguson et aI., 
1998; Landry et aI., 1997). 
FGF2 is at least one of the local factors which influences the balance 
between proliferation, differentiation, and apoptosis near to the 
coronal suture (Iseki et aI., 1997; Iseki, Wilkie and Morriss-Kay, 
1999; Kim et aI., 1998). In cases of a FGFR2 mutation-linked 
craniosynostosis, an increase in receptor-signalling results (Neilson 
and Friesel, 1995; Neilson and Friesel, 1996; Galvin et aI., 1996; 
Mangasarian et aI., 1997; Robertson et aI., 1998). Because of this, the 
FGFR2-expressing osteogenic precursor cells are forced to undergo 
premature bone differentiation (Iseki, Wilkie and Morriss-Kay, 1999) 
or to undergo apoptosis at an earlier stage at the expense of 
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proliferation. Both cells appear to deliver elements for 
craniosynostosis development; osteoblasts by producing osteoid and 
apoptotic cells by enhancing mineralization. As a result the 
proliferating cell population is exhausted and the gap between the 
frontal and parietal bones is fIlled with mature bone cells, eventually 
leading to suture obliteration. Indeed, Lomri et al. (1998) found an 
increase in maturation of the preosteoblastic calvarial cells derived 
from Apert patients and fetuses, leading to increased matrix formation 
and premature calvaria ossification. 
Although the FGFR2 gene is most commonly associated with 
craniosynostosis syndromes, it is interesting to theorize on how 
mutations in the FGFR1, FGFR3 or TWIST genes also lead to similar 
effects in developing sutures. FGFRI transcripts appear to be 
expressed by more differentiated bone cells compared to FGFR2 
(Iseki, Wilkie and Morriss-Kay, 1999). This might suggest a similar 
pathogenesis for FGFRI mutations, in which a later onset of 
disturbance of development would be expected. Besides expression 
comparable to that of FGFR2, FGFR3 transcripts have also been 
found within chondrocytes situated underneath the coronal suture 
(Iseki, Wilkie and Morriss-Kay, 1999) but its interaction with the 
suture is unknown. Consistent with our results, FGFR3 mutations 
resulting in thanatophoric dysplasia through ligand-independent 
receptor activation have been reported to induce premature apoptosis 
of chondrocytes (Legeai-Mallet et aI., 1998). 
This study has made some contribution in understanding sutural 
biology and the disturbances leading to craniosynostosis, but many 
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features of the suture and the congenital malfonnation remam 
unraveled. 
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IV.I. Pfeiffer syndrome resulting from a Ser351Cys mutation in 
the fibroblast growth factor receptor-2 gene. 
Mathijssen 1MJ, Vaandrager JM, Hoogeboom AJM, Hesseling-
Janssen ALW, Van Den Ouweland AMW. 
Journal of Craniofacial Surgery 9: 207-209,1998. 
Note: Okajima et al. (1999) further described the severe phenotype of 
the Ser35 I Cys mutation, in particular the associated ocular 
anterior chamber dysgenesis. 
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Pfeiffer's Syndrome Resulting From an 
S351 C Mutation in the Fibroblast Growth 
Factor Receptor-2 Gene 
I. M. J. Mathijssen, MO' 
J. M. Vaandrager, MO' 
A. J. M. Hoogeboom, PhD, Mot 
A. L. W. Hesseling-Janssen, MSct 
A. M. W. van den Ouweland, PhOt 
Rorterdam, The Netherlands 
For four of the most well-known craniosynostosis 
syndromes-Apert's, Crouzon's, Pfeiffer's, and 
Jackson-Weiss' syndromes-mutations in the fibro-
blast growth factor receptors (FGFRs) have been 
described. These substitutions arise mainly in the 
FGFR-2 gene and to a much lesser degree in the 
FGFR-l and FGFR-3 genes. We present a patient 
with an apparently sporadic type of Pfeiffer's syn-
drome, exhibiting nearly all associated features of 
this syndrome. A mutation in the FGFR-2 gene was 
found, namely serine351-cysteine. This mutation 
has been reported in only one patient so far, whose 
phenotype could match both Crouzon's and Pfe-
iffer's syndromes. 
Key Words: Fibroblast growth factor receptor, Pfe-
iffer' 5 syndrome, genetics 
Craniosynostosis can be defined as the pre-mature fusion or agenesis of cranial su-tures, resulting in an abnonnal morphol-ogy of the skull. This feature can be either 
solitary (Le., isolated or nonsyndromic craniosynos-
tosis) or in combination with other con9.enital disor-
ders (i.e., syndromic craniosynostosis). In syndro-
inic cases, the associated anomalies are primarily 
those of the hand and feet. The best known syndro-
mic types of craniosynostoses are Apert's, Crou-
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zon's, Pfeiffer's, Saethre-Chotzen, and Jackson-Weiss' 
syndromes. Only A pert's syndrome can clinically be 
diagnosed with great certainty because these pa-
tients exhibit symmetrical complex (bone and soft 
tissue) syndactyly of both hands and feet, apart from 
the synostotic coronal sutures and a wide gap in the 
skull at the site of the metopic suture at birth. Crou-
zon's syndrome is diagnosed by the presence of bi-
lateral exophthalmos and maxillary hypoplasia, with 
the absence of hand and feet anomalies. At birth the 
calvarial sutures are patent in most cases; pansynos-
tosis (closure of all cranial sutures) develops with 
time. Pfeiffer's and Saethre-Chotzen syndrome pa-
tients demonstrate bilateral involvement of the coro-
nal suture, like Apert's syndrome patients. In addi-
tion, Pfeiffer's syndrome is characterized by broad 
thumbs or broad halluces, whereas in Saethre-
Chotzen syndrome patients usually present with a 
simple (soft tissue) incomplete syndactyly of hands 
or feet apart from eyelid ptosis and a low-set hair-
line. Jackson-Weiss' syndrome reveals the facial 
characteristics of Pfeiffer's and Saethre-Chotzen syn-
drome but is only associated with foot abnormalities, 
such as broad first metatarsals and fused tarsal 
bones. Saethre-Chotzen syndrome is the only one ot 
these five in which the mutation was traced not in 
the FGFR genes but in the TWIST gene. A review of 
all publiShed mutations in craniosynostosis was pre-
sented by Wilkie? The mutation S351C identified in 
our patient with Pfeiffer's syndrome has been re-
port~d once in .a jatient with an unclassified type of 
cranIOsynostosIS. _ 
PATIENT 
A t birth, a female infant, the fIrstborn of her par-ents, presented with multiple congenital malfor-
mations, namely bilateral synostosis of the coronal 
sutures, exophthalmos, hypertelorism, coloboma of 
the left eye, hypoplasia of the maxilla, choanal atre-
sia, depressed nasal bridge, protrusion of the tongue, 
high arched palate, and an enlarged frontal fonta-
nelle. Furthermore, vision and hearing were im-
paired. Because she suffered from progressive air-
way obstruction, necessitating"a tracheotomy at the 
age of 2 months, she was referred to Our children's 
hospital. 
At examination, broad thumbs and halluces 
were evident, pathognomonic for Pfeiffer's syn-
drome. X-ray films of her hands and feet confirmed 
broad distal phalanges of both thumbs and broad 
halluces. The patient suffered from epilepsy, and a 
computed tomographic scan revealed a mild hydro-
cephalus. Magnetic resonance imaging showed 
Dandy-Walker complex type B .. a retrocerebellar 
arachnoidal cyst, cerebellar hypoplasia, corpus callo-
sum aplasia, and hypoplasia of the optic nerves. A 
monobloc procedure was undertaken at the age of 3 
months. As intracranial pressure raised, a ventricu-
loperitoneal drain was inserted. To ascertain the di-
agnosis of Pfeiffer's syndrome, blood samples for de-
oxyribonucleic acid (DNA) analysis were taken from 
the patient and her parents, who were seemingly un-
affected. 
MATERIALS AND METHODS 
D NA was isolated from peripheral blood cells ac-cording to standard procedures. 
Exon Amplification 
To identify the mutation, polymerase chain reaction 
(PCR) analysis was performed of exon 5 of the fibro-
blast growth factor receptor (FGFR)-1 gene and exon 
9 of the FGFR-2 gene. PCR primers for amplification 
of exon 9 of FGFR-2 were forward: 5' -CACAATCA T-
TCCTGTGTCGT-3' and extended at the 5' end with 
the -21M13 FOR primer and the reverse primer: 5'-
AACCCAGAGAGAAAGAACAGT-3' with an ex-
tension at the 5' end with the -29M13 REV primer. 
The length of the nonnal PCR product is 225 bp 
(without M13 sequence extension). 
PCR conditions for 100 ",I were 1 mM. MgCI2, 
0.5 mM. spermidine, 34 pmol of each primer, 200 
",mol mix of ,dATP, dCTP, dGTP, and dTIP, 0.05% 
W-1, 2 U Taq polymerase (Gibco BRL), 800 ng geno-
mic DNA. Thermal cycle conditions were 10 minutes 
at 95°C, followed by 35 cycles of 30 seconds at 95°C, 
30 seconds at 55°C, 90 seconds at noc, with a final 
elongation of 10 minutes at 72°C. 
Sequence Analysis 
For direct sequence analysis of the PCR products, 100 
ILl of PCR product was purified with the Qiaquick 
PCR purification kit' (Qiagen). The ready reaction 
dye primer cycle sequencing kit -21M13 and M13 
reverse AmpliTaqFS (Perkin Elmer) was used. 
Allele-Specific Oligonucleotide Hybridization 
For the allele-specific oligonucleotide (ASO) hybrid-
ization, the sequence of the "normal" oligonucle-
otide was 5'-GGGATATCCTTICAC-3' and for the 
"mutant" oligonucleotide 5'-~GATATGCTTT­
CAC-3'. Hybridization was performed at 37°C for 60 
minutes. Filters were washed to 0.1 x sse + 0.1% 
SOS for 5 minutes at 37°C. 
RESULTS 
D irect sequence analysis of PCR products of exon 5 of the FGFR-1 gene did not reveal any muta-
tion. Sequence analysis of exon 9 of the FGFR-2 gene 
identified the nucleotide substitution C into G at po-
sition 1064, resulting in the amino acid substitution 
of serine at position 351 into cysteine. Using ASO 
hybridization, the presence of the S351C mutation 
was confirmed in DNA of the patient and was absent 
in DNA isolated from peripheral blood cells of her 
parents. 
DISCUSSION 
We describe a mutation associated with a spo-radic case of Pfeiffer's syndrome, which was 
previously found in a patient presenting with a 
Crouzon's and Pfeiffer's syndrome-like appearance? 
Both the type of substitution (cys for ser) and its 
locus were considered to favor the classification of 
Crouzon's syndrome. In our patient, all malforma-
tions are consistent with Pfeiffer's syndrome, -relat-
ing this clinically depicted syndrome to the S351C 
mutation. So far, no correlation could be established"" 
between phenotypic features and specific FGFR gene 
mutations. Probably all these slightly different alter-
ations in the FGFRs result in a basically similar bio-
chemical effect, affecting both skull .and hand devel-
. opment. The varying clinical presentations could 
possibJy be caused by different genetic background 
(&g., modifying genes) of each individual. These 
modifying genes could .. for instance, cause a different 
time of onset of the mutated gene or cause a varying 
degree of its expression. The influence of the genetic 
background can thus be reflected in the observed 
outcome and alter the resulting phenotype. 
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The FGFR-2 gene is the only one of the involved 
FGFR genes for which the expression pattern during 
skull development has been established.4 Its tran-
scripts are mainly located in the re~on of the future 
coronal sl.,lture, whereas no FGFR-2 expression was 
found in other presutural regions in the examined 
developmental stages. The altered FGFRs appear to 
result in ligand-independent signaling!.s Mimicking 
this increase in function by applying FGF during co-
ronal suture development in the mouse (15 days 
postconception) resulted in premature differentia-
tion of osteogenic stem cells in the sutural area.4 
However, no true synostosis was observed. Cur-
rently, we are investigating the role of apoptotic 
(programmed) cell death in craniosynostosis, be-
cause this process is partially regulated by the FGFs 
and their receptors.6 An earlier- study demonstrated 
apoptosis to take place during normal embryogen-
esis of cranial sutures? Inhibition of apoptosis 
through enhanced FGF IFGFR signaling appears to 
contribute to the development of craniosynostosis, as 
injection of FGF during the developmental stage in 
which apoptosis takes place (starting from 16 days 
postconception) led to true fusion of the murine su-
ture.s At this stage, the exact role of apoptotic cell 
death in the pathogenesis of craniosynostosis is still 
under investigation. 
Although DNA isolated from peripheral blood 
cells of the parents is negative for the S351C muta-
tion, this does not exclude the possibility that one of 
the parents is a germline mosaic. Therefore, for the 
parents of our patient, the recurrence risk of having 
another affected child might be up to 50%. On the 
other hand, a correlation between increased paternal 
age and the high rate of mutations in FGFRs appears 
to exist.9 The father of our patient was 42 years of age 
at the time of the patient's birth; he had two older, 
healthy children from a previous marriage. 
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Apart from the contribution of DNA analysis in 
family counseling and prenatal diagnostics for cra-
niosynostosis syndromes, the use of genotypic-
phenotypic characterization as a classification tool 
for craniosynostosis is not yet conclusive. Such a 
classification is to be expected once the interactions 
of the genetic package are understood. 
We thank Dr Christl Vermeij-Keers for critically reviewing this 
article. 
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Abstract 
In about 50% of cases with syndromic craniosynostosis a genetic 
mutation can be traced. For the purpose of adequate genetic 
counseling and treatment of these patients the full spectrum of clinical 
findings for each specific mutation needs to be appreciated. The 
Pr0250Arg mutation in the FGFR3 gene is one of the most frequently 
encountered mutations in craniosynostosis syndromes. A number of 
studies on relationship between genotype and phenotype concerning 
this specific mutation have been published. Two Dutch families with 
the Pro250Arg mutation were screened for the reported characteristics 
of this syndrome and for additional features. New phenotypical 
findings of the Pr0250Arg mutation were hypoplasia of the frontal 
sinus, strabismus with vision impairment, dysplastic elbow joints with 
restricted elbow motion, and mild cutaneous syndactyly. Incidentally, 
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polydactyly, severe ankylosis of the elbow and fusion of cervical 
vertebrae were found. Of carpal and tarsal fusion, suggested to be 
pathognomonic for the Pro250Arg syndrome, only the latter was 
confirmed to be a hallmark in one family. 
Introduction 
Genetic mutations related to craniosynostosis syndromes can be traced 
in the genes encoding for the fibroblast growth factor receptor (FGFR) 
I, FGFR2, FGFR3 and in the TWIST gene. The Pr0250Arg mutation 
within the FGFR3 gene (first reported by Bellus et aI., 1996) is 
probably the most common mutation in genetic craniosynostosis. 
Moloney et al. (1997) demonstrated that the mutation rate at this locus 
is one of the highest known in the human genome. During the last few 
years this mutation has been found in cases with apparent isolated 
coronal synostosis and in families that initially were diagnosed with 
craniosynostosis-brachydactyly syndrome (Glass et aI., 1994), 
Saethre-Chotzen syndrome (Von Gemet et aI., 1996; Paznekas et aI., 
1998), Jackson-Weiss syndrome (Ades et aI., 1994) and Adelaide type 
craniosynostosis (Hollway et aI., 1995). This illustrates how difficult it 
can be to distinguish the different craniosynostosis syndromes from 
one another given their overlapping characteristics (Passos-Bueno et 
aI., 1999). Traditionally, the associated malformations of the face and 
extremities are the hallmarks for syndrome delineation. With the 
discovery of genetic mutations in craniosynostosis a new tool for 
classification seemed to be at hand. Therefore, the relationship 
between genotype and phenotype became relevant. Recognition of the 
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entire spectrum of a gIven mutation is of importance for genetic 
counseling and patient care. Of course, genotype/phenotype 
correlation for mutations causing a very consistent and/or severe 
clinical presentation is most easily recognized. An example of such a 
consistent phenotype is the Apert syndrome, with full penetrance and 
a dramatic phenotype. The number of mutations that are known to 
cause Apert syndrome is limited to five (Wilkie et a!., 1995; Oldridge 
et a!., 1997; Oldridge et a!., 1999), although 99% of the cases suffer 
from either Ser252Trp or Pro253Arg mutations in FGFR2 (Anderson 
et a!., 1998). Another mutation of which all carriers are severely 
affected in a rather uniform way is the Ser351 Cys mutation of the 
FGFR2 gene (pulleyn et a!., 1996; Gripp et a!., 1998a; Mathijssen et 
a!., 1998; Okajima et a!., 1999). However, for most craniosynostosis 
causing mutations, especially those in FGFR2, the phenotypes are 
heterogeneous. Perhaps consistencies between genotype and 
phenotype are yet undiscovered for some mutations because of the 
limited number of patients for each specific mutation within a 
craniofacial center. With respect to the FGFR3 Pro250Arg mutation 
and its clinical features several patients have been described. 
Combining these papers has resulted in a rather detailed description of 
abnormalities that may be encountered in carriers. Pro250Arg carriers 
can present with a wide range of cranial features, from normocephaly 
to macrocephaly, uni- or bilateral coronal synostosis or even a 
cloverleaf skull (Golla et a!., 1997). Facial characteristics may include 
midfacial hypoplasia, malocclusion, a high arched palate, 
downslanting palpebral fissures, hypertelorism, and ptosis. Other 
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encountered findings can be developmental delay or learning 
problems, congenital bilateral sensorineural hearing loss, broad 
thumbs and halluces without deviation, brachydactyly, and 
c1inodactyly. X-rays of the extremities may show broad and thimble-
like midphalanges, short metacarpal bones and midphalanges, absent 
or fused midphalanges, hypoplasia of the mid- and distal phalanges, 
cone-shaped epiphyses, and carpal (capitate-hamate) or tarsal 
(calcaneo-cuboidal or calcaneo-navicular) fusion (Reardon et aI., 
1997; Muenke et aI., 1997; Gripp et aI., 1998b; Graham et aI., 1998; 
Hollway et aI., 1998). Anomalies of the hand mostly involve the fifth 
ray. Incidentally, strabismus and slight partial syndactyly of the 
second and third toes or of the third and fourth fingers are reported 
(Von Gernet et aI., 1996). But even a normal aspect of the skull, face 
and limbs with normal intelligence is part of the spectrum (Robin et 
aI., 1998). Lajeunie et al. (1999) demonstrated that females were 
significantly more severely affected than males. In two families within 
our craniosynostosis population new features of this mutation were 
detected, while the presence of previously reported malformations was 
either confirmed or absent. Here the clinical presentation of two 
families is brought, with 8 and 4 affected members respectively. 
Material and Methods 
DNA analysis 
DNA was isolated from peripheral blood cells according to standard 
procedures. 
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To identify the mutation P250R in exon 7 of the FGFR3 gene, allele 
specific oligonucleotide hybridization was undertaken. PCR primers 
used to amplify exon 7 were forward: 5'-
TCGGCAGTGACGGTGGTGG-3' and the reverse primer: 5'-
GGAGCCCCAGCGGCGGC-3'. The length of the PCR product is 
296bp. 
PCR conditions for lOO III reactions were hnM MgCI 2, 66 pmol of 
each primer, 200 1Lffi01 mix of dATP, dCTP, dGTP and dTTP, 0.05% 
W-l, 4U Taqpolymerase (Gibco BRL), 800ng genomic DNA. 
Thermal cycle conditions were 10 minutes at 95°C followed by 35 
cycles of 45 seconds at 95°C, 45 seconds at 60°C, 90 seconds at noc, 
with a final elongation of 10 minutes at noc. 
The sequence ofthe " normal" oligonucleotide was 5'-
GAGCGCTCCCCGC-3' and for the "mutant" oligonucleotide 5'-
GCTCCCGGCACCG-3'. Hybridization was performed at 40°C for 60 
minutes. Filters were washed to 0.3 X SSC + 0.1 % SDS for 5 minutes 
at 40°C. 
Family 1 
Of this three generation family 12 persons were available for 
screening (fig. 1, table 1). Looking at their family albums, it is very 
likely that the mother of 1:2 was affected as well, just like at least 
three of her 12 other children (7 females, 5 males; not illustrated in 
fig. 1). Two of these three daughters appear to have had affected 
daughters themselves, although not confirmed genetically. 
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Only one girl (III:2) in this family was recognized to be affected with 
craniosynostosis and operated on. Eight persons (4 men, 4 women) 
were carriers of the Pro250Arg mutation. Five mentioned recurrent 
otitis media, one had recurrent frontal sinusitis (II: I), two suffered 
from epilepsy requiring medication, one complained about frequent 
headaches, one was diagnosed with benign neoplasias of the vocal 
cords, and one had a benign process near the right mandible surgically 
removed. All were within the normal range for length and weight. 
Three (II:4, II:5, III:3) had developmental delay necessitating special 
schooling. Head circumferences ranged from below p3 (n=I), plO 
(n=I), between plO and p25 (n=I), and between p50 and p75 (n=5). 
Midfacial hypoplasia was observed in three. All carriers had a narrow 
and high arched palate. Other abnormalities concerning the eyes, 
orbits, sight and hearing are enlisted in table I. X-rays of the skull 
indicated hypoplasia of the frontal sinus in five (fig. 2) possibly six, 
but the hypoplasia in this patient (III:2) could also be the result of her 
supraorbital advancement. One affected girl (III:3) suffered from 
fusion of the spinous processes of the second and third cervical 
vertebrae. Furthermore, she had a severe loss of extension of her 
elbows due to dysplastic elbow joints (fig. 3) combined with slight 
bowing ofthe radius. 
Mild cutaneous syndactyly of the hands between digits III and IV was 
noticed in five family members, and brachydactyly in six (3 affecting 
all digits, 3 only of the little finger; table I). Never did we detect 
carpal fusion on the X-rays of these 8 carriers. The encountered feet 
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anomalies are reported in table I. X-rays of the feet were only 
available in two, in whom tarsal fusion was noticed once. 
Family 2 
Based on pictnres of her parents, brothers and sisters, the grandmother 
1:2 appeared to be the one in whom the mutation arose de novo. Four 
persons were proven to be carriers of the Pro250Arg mutation (fig. 1). 
With the exception of the youngest of the family (III:6) no one had 
undergone any form of craniofacial surgery. During childhood one 
(II:2) was operated for correction of her strabismus and two (II:2, II:3) 
had ventilation tubes placed to treat their deafuess. The grandmother 
and her two affected daughters were all wearing glasses ever since 
childhood. Having missed the diagnosis of craniosynostosis, helmet 
treatment was applied to correct the head asymmetry in daughter II:3 
during the period of one to four years of age. All were within the 
normal range for length and weight. Those positive for the mutation 
had significant learning difficulties requiring special schooling. Head 
circumferences were near plO (n=l), p50 (n=2), and p75 (n=l). 
Confirmed hallmarks of the Pro250Arg syndrome in this family were 
plagio- or brachycephaly, hypertelorism, deafuess, and brachydactyly, 
while restriCted elbow extension, strabismus with reduced vision were 
new related featnres (table 2). None of the carriers had midfacial 
hypoplasia but all had a high arched palate that was narrow in front. 
For this malformation the grandmother was treated with a palatal 
brace when she was a child. Each of the three adult carriers had 
numerous teeth extracted because of crowding and ad random 
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positioning. The hair was noticed to be thick and abundantly present, 
having a characteristic distribution with the hair directed anteriorly 
and upward. Hypoplasia of the frontal sinus was again frequently 
encountered. In all three available X-rays of the feet synostosis of the 
navicular and cuboid bones was found. The grandmother had a 20° 
extension deficit of the right elbow and the X-rays of both her elbows 
indeed only showed ankylosis on the right side. Her first daughter 
(II:2) had an extension deficit of both elbows with dysplastic elbow 
joints on X-ray, while in the grandson (III:6) pronation was limited. 
Quite surprisingly, II:4 turned out negative for the Pro250Arg 
mutation four times, using four blood samples which were obtained on 
two separate occasions, although he shared numerous craniofacial 
characteristics with his sibs. His head was brachycephalic with a 
marked retrusion and elongation of the forehead. Besides a long face, 
his upper and lower jaw were nonnal developed and adequately 
positioned. There was hypertelorism and he had undergone surgical 
correction for strabismus on one eye. Ever since he was a child he 
wore glasses, but his hearing was undisturbed. He also suffered from 
significant learning difficulties. Nearly all his teeth had been removed 
as they were numerous and at random positioned. His palate was high 
but not narrowed. While his hands and elbows were clinically nonnal, 
his feet revealed small digits V. X-rays of his hands were nonnal but 
those of his feet showed navicular-cuboid fusion on both sides. 
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Figure 1. Pedigrees of family 1 and 2 with respectively eight and four 
genetically proven carriers of the Pro250Arg mutation (_ and e). 
Persons that were shown not to carry the Pro250Arg mutation are 
indicated with (n). Member II:4 of family 2 is suspected to carry the 
mutation although this has not been proven yet. 
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Figure 2. Skull X-ray of member II:2 of family 2 at age 34 showing 
hypoplasia of the frontal sinus. 
Figure 3. X-ray of the right elbow of member III:2 of family 1 at age 
13 revealing a dysplastic elbow joint. 
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Patient head X-skull eyes and orbits sight heariug hands/elbows X-hand feet X-feet 
1:2 brachy hypoplasia supraorb. depr. glasses J- nonnal nonnal nonnal 
frontal sinus telecanthus 
II: I brachy hypoplasia supraorb. depr. nonnal J- cut. syndactyly nonnal polyd., dyspl. PPh, 
frontal sinus, hypertelorism cut.syn- fusion MPh-
diastasis C2 dactyly DPh dig V 
11:2 nonnal nonnal nonnal nonnal nonnal cut. syndactyly, nonnal hypopl. 
brachyd. of dig III 
all digits 
11:3 brachy hypoplasia orb. dystopia, glasses J-J- cut. syndactyly, hypopl. nonnal -
frontal sinus exorbitism brachyd. dig V MPh V 
11:4 brachy hypoplasia strabismus, glasses J- cut. syndactyly nonnal nonnal -
frontal sinus iris coloboma, 
supraorb. depr., 
orbital dystopia, 
hypertelorism 
nystagmus 
11:5 plagio hypoplasia strabismus, orb. nonnal nonnal brachyd. of nOlTIlal nonnal calcaneo-
frontal sinus dystopia all digits naviculare 
fusion 
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Patient head X-skull eyes and orbits sight hearing hands/elbows X-hand feet X-feet 
III:2 plagio frontal sinus? strabismus, orb. glasses normal cut. syn-, hypopl. cut.syn- -
dystopia, down- dactyly, MPh V dactyly 
slant eyelids brachyd. dig V 
III:3 normal fusion sp.proc.C2-C3 strabismus, glasses H brachyd. dig V, hypopl. hypopl. 
hypertelorism flex. contracture MPh V dig III 
upslant eyelids elbows 
Table I. Phenotypes of the Pro250Arg mutation carriers in family 1. 
Abbreviations: CS = coronal suture synostosis; orb. = orbital; supraorb. depT. = supraorbital depression; 
sp.proc. = spinous processes; 
brachyd. = brachydactyly; cut. = cutaneous; dyspl. = dysplasia; DPh = distal phalanx; MPh = midphalanx; PPh 
= proximal phalanxhypopl. = hypoplasia; polyd. = polydactyly; flex. = flexion. 
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Patient head X-skull eyes and orbits sight hearing handslelbows X-hand feet X-feet 
1:2 brachy hypertelorism glasses t 20° ext. deficit normal normal N-C 
r-elbow fusion 
11:2 brachy hypoplasia strabismus, glasses U 20° ext. deficit llOlTIlal normal N-C 
frontal sinus hypertelorism r/l-elbow fusion 
11:3 plagio unilateral strabismus, glasses t brachyd. of hypopl. normal N-C 
hypoplasia orb. dystopia, all digits, esp. MC's+ fusion 
fi'ontal sinus hypertelorism dig V phalanges 
III:6 brachy bilateral CS hypertelorism n? U brachyd. of pseudo- normal 
all digits; limited epiphyses 
pronation 
Table 2. Phenotypes of the Pro250Arg mutation carriers in family 2. 
Abbreviations: CS = coronal suture synostosis; orb. = orbital; 
PPhll, 
cone-shaped 
MPh's 
brachyd. = brachydactyly; hypopl. = hypoplasia; MPh = midphalanx; PPh = proximal phalanx; 
MC = metacarpal bone; MT = metatarsal bone; N-C = navicular-cuboid bones; 
ext. = extension; I = left; r = right. 
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Discussion 
The known variation in head shape in Pro250Arg mutation carriers 
was represented in our families, together with most of the facial 
characteristics. Developmental delay and hearing problems were also 
frequently encountered. However, none of the affected members 
suffered from carpal fusion although this was a consistent finding in 
the two families reported by Graham et al. (1998). Another reported 
common feature is the reduced length of the little finger. In the 
families described by Graham et al. (1998) a reduced length of the 
fifth metacarpal, with or without involvement of the middle and/or 
distal phalanges was in most cases the underlying cause. Our patients 
mainly had a shortened and dysplastic middle phalanx of the fifth 
fmger. Applying the presence of hand abnormalities as predictor for 
carriership was very reliable in the first family, but not in the second 
(8/8 versus 2/4). Tarsal fusion, seen as navicular-cuboid fusion, 
appeared to be the most consistent presentation in the second family. 
New features that were commonly present in our families are 
hypoplasia of the frontal sinus, strabismus with vision impairment, 
dysplastic elbow joints with limited elbow motion, and mild cutaneous 
syndactyly. New but possibly incidental findings are polydactyly, and 
fusion of spinous processes of cervical vertebra. 
Interestingly, the carriership of one clinically evidently affected 
person in family 2 could not be proven. A possible explanation for this 
finding could be that he is carrying another mutation in the vicinity of 
position 250 in the FGFR3 gene, which disturbs the functioning of the 
applied primer. Further analysis is therefore being conducted. 
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Given the high prevalence of the Pr0250Arg FGFR3 mutation it seems 
appropriate to start analysis for this specific mutation, especially when 
there are no overt manifestations of other syndromic forms. Clinical 
recognition can be relatively easy if carpal or tarsal fusion is present 
but one should not reject the possibility ofPro250Arg carriership in its 
absence. Furthermore, there are no data on the incidence of 
carpal/tarsal fusion in other craniosynostosis syndromes. Being 
familiar with the variable presentation of this syndrome helps to 
recognize patients as such, although the genetic analysis remains 
essential. Once the Pr0250Arg mutation is detected genetic analysis 
should be offered to all family members at risk. 
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GENERAL DISCUSSION 
Classification of craniosynostosis 
The clinical classification of craniosynostosis syndromes, based upon 
associated malformations of the face and extremities, was shown to be 
insufficient (chapter I.l). Often no conclusive diagnosis can be made 
due to overlapping features, which is a major drawback given the 
impact on care. For example, comparison of surgical outcomes can 
only be undertaken when consensus exists on diagnosis. Our first 
morphological study (chapter II. I ) was undertaken for classification 
purposes but eventually did not meet its goal. The genetic basis of 
craniosynostosis syndromes was thought to be a reliable and objective 
foundation for a new classification system. Disappointingly, genotype 
and phenotype often do not match. One mutation can give rise to a 
variety of abnormalities in various degrees (chapter IV.2), while a 
similar phenotype can be caused by numerous mutations, even in 
different genes (chapter I.2). Nonetheless, the analysis of geno-
phenotypic correlation is undertaken and being reported because of 
the possible clinical importance (below). A number of similar articles 
describe the various types of mutations found in a certain clinically 
designated syndrome instead of vice versa. It would be more sensible 
to describe the phenotypic spectrum for individual mutations. 
Ultimately, a classification system for craniosynostosis with 
implications for specific care should be developed. Whether or not 
genetics will be the foundation remains to be seen. At present, we are 
still far off from a classification that can be implemented clinically. 
Until such a classification is introduced, we suggest to designate 
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patients according to the traditional classification combined with the 
mutation if detected. The clinical diagnosis should be applied as 
guideline for genetic analysis, pointing out the most likely mutation 
site. The coinciding of, for example, the clinical diagnosis of Saethre-
Chotzen syndrome with the TWIST mutations can highly increase the 
efficiency of genetic screening. For the whole Saethre-Chotzen group 
with TWIST mutations a rather circumscribed clinical presentation is 
outlined, which currently can not be specified to type of mutation. It 
does seem to be justified to reserve the diagnosis of Saethre-Chotzen 
syndrome only for those patients with a proven TWIST mutation and 
to reclassifY those with a FGFR mutation. A substantial number of 
patients suggestive for Saethre-Chotzen syndrome remain, in whom 
no mutation is detected yet. These groups should be separated by 
adding 'TWIST-positive or TWIST-negative' to the diagnosis of 
Saethre-Chotzen syndrome. 
The number of mutations in FGFRI and FGFR3 are limited and their 
phenotypes are fairly precisely mapped. This makes it more 
informative to speak of a FGFRI-Pfeiffer syndrome, indicating a mild 
presentation, instead of just Pfeiffer syndrome. FGFR3 Pro250Arg 
syndrome still requires an indication of the individual's phenotype 
given the associated wide range of presentation. This mainly leaves us 
with the patients with a FGFR2 mutation, in whom the largest spread 
in presentation is found. Particularly in these patients one needs to be 
cautious in labeling them with only the classical diagnoses such as 
Pfeiffer, Crouzon or Jackson-Weiss syndromes. Especially the last 
syndrome seems to be exclusively related to the Ala344Gly mutation. 
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Future geno-phenotypical analysis should be focused on FGFR2 
mutations. In half of the number of patients no mutation can be 
detected at present, leaving them with just diagnoses of the classical 
classification. Of course this does offer the clinician a guideline by 
which patients have been treated for over thirty years now. The 
current knowledge on the relationship between genotype and 
phenotype can however be applied directly, in both pre- and postnatal 
care. 
In a pregnancy with known carriership of a craniosynostosis mutation 
in one of the parents, amniotic fluid puncture or chorion villus biopsy 
may exclude or confirm carriership of the child. If the range of 
phenotypic presentation is established for the mutation in question, 
more specific genetic counseling can be offered. In case of a 
consistent relationship between genotype and phenotype, such as the 
FGFR2 mutation Ser35ICys (chapter IV.I), a reliable prediction on 
mental and physical status can be given. However, if it for instance 
concerns the most commonly encountered mutation Pr0250Arg in 
FGFR3, predicting the phenotype becomes a wild guess (chapter 
IV.2). The presence or absence of craniosynostosis in the infant can 
then only be determined prenatally through an additional ultrasound. 
Because ultrasound doesn't have any of the associated risks that 
punctures or biopsies have, this test might even be considered instead 
of prenatal mutation analysis in specific cases such as the Pro250Arg 
mutation. New developments in the field of 3-dimensional ultrasound 
may further enhance the possibility to detect craniosynostosis and 
other congenital malformations, also in the non-genetic cases. 
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Skull development 
The morphological studies of the cranium enabled us to trace the 
developmental stage during which the synostosis was initiated 
(chapter 11.2). For each suture the period of development was stated 
and thus can its synostosis be detected from that time on. The metopic 
suture is the fIrst of the cranial sutures to develop at about 15 weeks of 
gestation, soon followed by the coronal sutures. Theoretically, the 
fusion between the frontal and parietal bones in coronal suture 
synostosis can be visualized ultrasonically from 16 weeks of gestation 
onwards. Routine prenatal screening by ultrasound for congenital 
malformations does however not include the search for 
craniosynostosis. This is questionable given the estimated frequency 
of 1 in 2,000-2,500 births that makes craniosynostosis everything but 
the rare disorder it is generally thought to be. Other associated 
malformations besides those of the extremities such as deafness, 
mental retardation and visual impairment can at present not be tested 
prior to birth. 
Once the child is born, specific screening and treatment should be 
performed in relation to the mutation. For instance, outcome of 
craniofacial intervention in patients with the Pr0250Arg mutation in 
FGFR3 has been shown to be worse compared to patients without 
mutation (Renier et a!., 2000). This is mainly due to the associated 
severe bulging of the temporal fossae, which should thus be addressed 
during surgery. 
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Given our limited knowledge on geno-phenotypic relations, unknown 
associated malformations will remain undetected. In light of this, there 
is the need to keep reporting additional clinical findings. Furthermore, 
screening of patients should at present be performed more extensively 
to further delineate the mutation specific phenotypic spectrum. 
Another aspect of the discovery of the FGFR and TWIST mutations in 
craniosynostosis is the detection of mutations in patients who were 
originally diagnosed as isolated cases of craniosynostosis. 
Subsequently, mutation carriers were identified who were very mildly 
affected or normal. This is of major importance given their 50% risk 
of passing the mutation on to their offspring. Generally, it is 
recommended to screen all patients with uni- or bilateral coronal 
suture synostosis in particular for the Pr0250Arg mutation in FGFR3. 
Also in cases where the metopic suture is involved, one should always 
be alert for an underlying syndrome (Lajeunie et aI., 1998). 
Pathoembryogenesis of craniosynostosis 
Our initial hypothesis of bone center displacement being a causal 
factor in craniosynostosis (Vaandrager et aI., 1995; chapter II.!, 
Mathijssen et aI., 1997a; Mathijssen et al., 1997b) was later proven to 
be wrong. Studies on the calvarial morphology of rabbit embryos 
suffering from coronal suture synostosis showed the bone center 
displacement to occur following the suture ossification (Mooney et 
aI., 1998; Dechant et aI., 1998; Dechant et aI., 1999). By studying 
both normal (chapter III.!) and abnormal development of the murine 
coronal suture (chapter IIL2), we attempted to disclose some aspects 
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of the pathogenesis. The focus was on the occurrence of apoptosis 
since we anticipated involvement of this process in the pathogenesis 
of craniosynostosis (chapter III. I ). During normal development 
apoptotic cells were traced near the osteogenic fronts of the frontal 
and parietal bones at the sites where they were in approximation. The 
sutural area itself remained free from apoptosis. The first apoptotic 
cells were detected in murine embryos of 16 days post conception. 
Rice and others (1999) later confirmed the timing and distribution of 
apoptotic cells we described. Combining these observations with the 
studies done by Iseki et al (1997; 1999) it appears that apoptosis is 
directly related to bone differentiation. Functionally, apoptosis may be 
involved in keeping the balance between proliferation and 
differentiation within the suture by reducing the number of cells that 
reach the stage of the osteocyte. Otherwise, it may well be that the 
remnants of the apoptotic cells contribute to the mineralization of the 
osteoid (Landry et aI., 1997; Ferguson et aI., 1998). Next, we tried to 
mimic the increased sigualling of the FGFR2 mutations by exposing 
the developing murine suture to extra FGF4 or FGF2 (chapter IIL2). 
Twenty four hours after the injection the sutures showed obliteration 
macroscopically. Initially, we reported this finding to be probably due 
to inhibition of apoptosis (Mathijssen et aI., 1999a) because this effect 
ofFGF4 had been reported in literature (Jung et aI., 1994; Chow et aI., 
1995; Macias et al., 1996). When histological samples became 
available quite the opposite appeared to be true. The number of 
apoptotic cells was markedly increased and these cells were located 
throughout the sutural area, from the frontal bone to the parietal bone 
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(chapter IIL2. Mathijssen et aI., 1999b). Bone differentiation, 
visualized by collagen type I expression, was enhanced 
simultaneously. The degree and extent of mineralization both 
increased, resulting in thicker bones which were in closer vicinity to 
each other at the sutural site. Using a similar mouse model, Iseki and 
coauthors (! 999) also demonstrated enhanced bone differentiation at 
the expense of proliferation within FGF2 exposed coronal sutures. 
Cultured osteoblastic cells derived from fused sutures from infants 
with craniosynostosis showed an increased maturation, matching the 
animal studies (De Pollack et al. 1996). Likewise, human calvarial 
cells with the Ser252Trp mutation in FGFR2 underwent premature 
osteoblast differentiation (Lomri et aI., 1998), which was associated 
with a down-regulation of FGFR2 in these cells (Lemonnier et aI., 
2000). The rate of proliferation of mesenchymal cells, preosteoblasts 
or osteoblasts was however not altered (Lemonnier et aI., 2000). 
Fragale et al. (! 999) grew osteoblasts positive for either the 
Pro253Arg or Cys342Arg FGFR2 mutation and osteoblasts from 
patients with a isolated craniosynostosis. All three celltypes revealed a 
lower proliferation rate and a marked differentiated phenotype in 
comparison to normal osteoblasts. 
Once the suture is ossified, causing fusion of the neighboring bone 
plates, growth of the skull can no longer take place at the affected 
suture but only at the remaining ones, giving rise to the characteristic 
distorted skull shape. Because growth within the suture has ceased, the 
bone centers get fixed at a certain distance from one another. This can 
be visualized as bone center displacement (chapter II.2) on dry skulls, 
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during operation and on CT scans of the skull. In retrospect, the theory 
of Park and Powers described in 1920 matches best with the view we 
currently have on the pathoembryogenesis of craniosynostosis. 
Given the still limited knowledge on normal suture biology, one can 
only try to explain the occurrence of craniosynostosis. All animal 
models, including our in vivo mouse model, are attempts to reproduce 
the human FGFR mutations. A normal FGF receptor exposed to an 
excess of ligand can not be expected to act identically to a mutated 
FGF receptor. Clarity on the remaining questions may come in the 
near future if the efforts to introduce FGFR mutations in a mouse will 
be successful, offering a more reliable craniosynostosis-model. 
Considerations and recommendations for future research and 
treatment 
Within the FGFR-related craniosynostosis syndromes the severity of 
disease may be related to the timing and degree of FGFR expression. 
Each mutation may have its own effect on the degree of receptor 
activation and thus on the degree of disturbance of the 
proliferation/differentiation balance, the amount of transcripts of the 
involved gene and on the ratio of isoforms. Of course, environmental 
effects and genetic background (Park et aI., 1995) influence the final 
outcome. In particular, subtle differences in local expression of FGFs 
might ultimately determine the severity of the phenotype. 
It is unclear why the sagittal suture is so rarely involved III the 
syndromic cases, although it is known to express FGFR2 at its 
osteogenic fronts during development (Kim et aI., 1998; Mehrara et 
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aI., 1998). Obviously, one cannot merely translate the findings for the 
coronal suture to the other sutures. Pathogenesis of the isolated forms 
of craniosynostosis, which is much more common than syndromic 
ones, remains obscure. Other sutures have been left out of the focus of 
this study, such as the squamosal suture. These aspects, including the 
associated congenital defects, will be a main topic of research for the 
commg years. 
The following two suggestions for alternative treatment in the future 
have been reported, which are both in my view unrealistic: 
1. The development of a specific inhibitors of FGFR signalling to 
inhibit receptor signalling in the involved patients during postnatal 
development (De Moerlooze and Dickson, 1997). Setting the technical 
abilities to construct such an inhibitor aside, this postnatal interference 
will probably be too late. In most cases, the erroneous FGFR 
signalling within the human coronal suture and resulting fusion 
already took place prenatally, just like the majority of its 
consequences on skull growth. Applying the Imagmary FGFR 
inhibitors at the appropriate prenatal periods should bring the solution, 
but would first require studies on the teratologic effects they might 
have. 
2. Surgical correction in utero. In a sheep model in utero surgical 
correction of the synostosis has been shown to fully correct or prevent 
the secondary malformations (Stelnicki et aI., 1998b). However, for 
the human situation the risks associated with intrauterine surgery 
don't outweigh the advantages of early correction postnatally for 
165 
craniosynostosis and is therefore not likely to be carried out for this 
indication in the near future. 
A somewhat more realistic alternative treatment for craniosynostosis 
could consist of transplanting bony stem cells into the reopened 
sutural area of the infant to replace the cells that were lost due to the 
genetic defect. A major drawback of this intervention is that probably 
environmental factors such as those produced by the dura mater are 
involved in sustaining this mitogenic population. Without the 
necessary input from its surroundings this newly grafted suture will 
probably ossify too. Again, this shows the need for more knowledge 
on how normal suture biology functions, in order to make a 
therapeutically application possible. 
Reviewing the dilemmas that existed concerning craniosynostosis and 
the result of our studies and those of others, a number of 
recommendations for future research can be made. In 50% of the 
patients with a clearly syndromic form of craniosynostosis still no 
mutation can be detected. Perhaps their genetic defects are within the 
known genes, but are yet undiscovered because of technical 
limitations. The reported number of new mutations within the FGFR 
and TWIST genes are however declining, making it more likely that 
other genes carry the mutation, most probably those that are involved 
in the same signalling network, given the similar phenotype. One 
suggested group of genes is for instance that encoding for the FGFs. 
In light of the genetic research, the gathering of blood samples of 
every patient with a possible syndromic form of craniosynostosis and 
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no detectable mutation so far is recommended. This may speed up the 
rate at which new candidate genes for craniosynostosis can be traced. 
In most craniofacial centers, like in ours, it is now protocol to 
undertake genetic mutation analysis for each new patient with 
(suspected) syndromic craniosynostosis. Our elderly patients with 
syndromic craniosynostosis have also been offered the opportunity to 
undergo this genetic consultation. Most individual craniofacial centers 
will still have a restricted number of patients for each specific 
mutation. In this light, a European study could enhance the search for 
genotype/phenotype correlations highly. The current estimate on the 
incidence of craniosynostosis states 1 in 2,000-2,500 live births 
(Lajeunie et aI., 1995a). Mangement of care for patients with 
craniosynostosis on a (inter)national level should be based on these 
numbers. In The Netherlands there is at present only one craniofacial 
center with a complete craniofacial team functioning according to the 
standards set by the American Cleft Palate and Craniofacial Society 
(1993) for a population of 15 million people. With nearly 200,000 
births a year, a total of 80 to 100 patients with craniosynostosis will 
be born every year. Given the restrictions regarding outpatient clinics, 
admitted surgical time and restricted capacity of the intensive care 
unit (ICU) at the Craniofacial Center Rotterdam, a bottleneck is 
already there. At present, this results in rather long waiting lists not 
only for craniofacial intervention but also, for instance, for treatment 
of hand malformations. In light of these perspectives, ICU capacity 
and the number of trainees in craniofacial surgery should be 
expanded, just like the number of craniofacial centers. It is however of 
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the essence that quality of care meets the required standards, 
especially for the complex disorder craniosynostosis. 
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V. SUMMARY 
Because of the insufficiency of the traditional classification system for 
craniosynostosis syndromes (chapter 1.1) an attempt was made to 
develop a new classification based on, amongst others, morphologic 
analysis of the calvaria and, later on, the genetic background of 
craniosynostosis. The morphologic studies of normal human fetuses 
describe the macroscopic development of the frontal and parietal 
bones with the coronal, metopic and sagittal sutures arising in between 
(chapters ILl and II.2). The tubers mark the locus at which the frontal 
and parietal bones started to ossify, i.e. the frontal and parietal bone 
centers. Growth of the bones spreads in a concentric manner from the 
bone centers on, which can be seen as a radiating pattern of the bones. 
Each suture is found to develop at a highly consistent period during 
the fetal period of embryogenesis, in a characteristic pattern. At 16 
weeks of gestation the first onset of the coronal suture can be seen, 
situated exactly in line with the frontal and parietal bone centers. It is 
at this locus that the frontal and parietal bones get in close contact 
first. Coronal suture development spreads from here on in both cranial 
and caudal direction. The metopic suture is formed from 15 weeks of 
gestation on and the sagittal suture development starts at 18 weeks. 
Observations done on dry fetal skulls and patients' skulls during 
surgery, or on their CT scans revealed typical displacement of the 
frontal and/or parietal bone centers for affected coronal, metopic or 
sagittal sutures. The associated bone centers were located just next to 
the synostotic suture and the radiating pattern of the bones was 
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disrupted. The altered positions of the bone centers point out the 
developmental stage at which the synostosis was initiated. The 
distance between the two bone centers correlates into the 
developmental stage at which the bone centers are physiologically 
positioned from one another and further growth between the bone 
centers was arrested due to synostosis of the suture. For the coronal 
suture this period was determined at about 16 weeks of gestation, the 
time at which the first onset of the suture arises. These results can be 
translated to the appropriate timing for prenatal screening for 
craniosynostosis through ultrasound. Although the findings of these 
morphological studies did result in clinically relevant findings, no new 
classification for craniosynostosis came from it. 
The genetic background of craniosynostosis appeared to be a better 
foundation for such a classification. This requires the mapping of 
phenotypic variations associated with each specific mutation. In a 
pilot study we analyzed this relation for all our patients with 
craniosynostosis for whom the mutation was known. For most 
mutations the number was too limited to allow meaningfull analysis. 
We reported the clinical findings in a patient with the Ser35lCys 
mutation in FGFR2 in view of the very severe phenotype (chapter 
IV.l). This phenotype is very similar to that of other individually 
described patients, indicating a strong relationship between genotype 
and phenotype for the Ser35lCys mutation. Furthermore, the FGFR3 
mutation Pro250Arg was highlighted because of its high incidence 
and the detection of additional findings in its phenotype within our 
population (chapter IV.2). At the present, a clinically fulfilling 
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classification based on genetics can still not be be developed. This is 
caused by a. the fact that in only half of the patients with a 
craniosynostosis syndrome a genetic mutation is traced, b. the number 
of patients for each individual mutation is very low, and c. the 
inconsistent interactions between genotype and phenotype for most 
mutations. 
The discovery of genes involved in craniosynostosis gave a new 
impulse to the research on its pathogenesis. Their expression and 
function during normal suture development are largely unknown, 
making it even more difficult to understand the mechanism through 
which they induce craniosynostosis. For this reason, the first 
experimental study concerned normal development of the coronal 
suture in mice (chapter III. I ). This study focused on the occurrence of 
progranuned cell death, i.e., apoptosis, since this process is known to 
be essential during embryogenesis and is involved in the pathogenesis 
of numerous congenital malformations. Apoptosis during coronal 
suture development was shown to take place from a specific stage on, 
16 days post conception, and at a restricted site, the osteogenic fronts 
of the frontal and parietal bones where these bones are in close 
vicinity. To study the biological processes resulting in premature 
suture ossification, a mouse model was developed in which the 
craniosynostosis associated fibroblast growth factor receptor (FGFR) 
2 gene mutation was mimicked (chapter III.2). Exposing the coronal 
suture of a mouse embryo to an ectopic dose of fibroblast growth 
factor (FGF) 2 or 4 through ex utero surgery achieved this. Results 
showed that bone precursor cells within the suture underwent bone 
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differentiation and apoptosis prematurely with enhanced 
mineralization of the osteoid. An attempt is made to translate the 
results of these studies to the human situation. It appears that the 
mutated receptor forces the expressing cells within the developing 
suture to undergo bone differentiation prematurely, at the expense of 
proliferation. As a result, ossification is enhanced while growth within 
the suture is restricted. Circumstantial evidence on the involvement of 
apoptosis in bone differentiation and mineralization is given by the 
associated increase of apoptotic cells within the treated murine suture. 
Thus, the genetic mutations in craniosynostosis cause a shift in the 
balance between proliferation and differentiation - including 
apoptosis - in the suture towards the latter. Given the similar 
morphological aspects of the calvaria in isolated and syndromic 
craniosynostosis, a comparable disturbance in developmental biology 
of the suture might underlie these congenital malformations. 
This study has dealt with aspects of classification, morphology, 
genetics, and pathogenesis of craniosynostosis. Although relevant 
findings resulted of both clinical as well as fundamental character, 
numerous unsolved features remain for which recommendations are 
given for future research (chapter V). 
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VI. SAMENVATTING 
Aangezien het klassieke classificatie systeem voor craniosynostosis 
syndromen tekortschiet (hoofdstuk I.1) werd gepoogd een nieuwe 
classificatie op te zetten, gebaseerd op onder meer morfologische 
analyse van de schedel en later op de genetische achtergrond van 
craniosynostosis. De morfologische studies van normale humane 
foetussen beschrijven de macroscopische ontwikkeling van de frontale 
en parietale beenderen waartussen zich de corona naad, de metopica 
naad en de sagittaal naad vormen (hoofdstukken II.I en II.2). De 
plaats waar de eerste ossificatie van de frontale en parietale botten 
optreedt, de zogenaamde frontale en parietale botcentra of botkernen, 
wordt gemarkeerd door de tubers. Vanuit de botcentra verspreidt de 
ossificatie zich in een concentrische manier, waardoor een radiair 
patroon in de botten ontstaat. BIke sutuur ontwikkelt zich binnen een 
zeer constante peri ode en in een karakteristiek patroon. De eerste 
aanzet van de corona sutuur is zichtbaar bij een gestatieduur van 16 
weken, ter plaatse van een denkbeeldige lijn welke de frontale en 
parietale botkernen verbindt. Op deze plaats naderen de frontale en 
parietale botten elkaar voor het eerst. De ontwikkeling van de corona 
naad verloopt vervolgens van hieruit naar zowel craniaal als caudaal. 
De aanleg van de metopica naad start bij 15 weken gestatie, terwijl de 
sagittaal naad begint bij 18 weken. 
Aan het schedeldak van droge foetale schedels en van patienten 
tijdens operatie of op de schedel-CT scan, kan een typische 
verplaatsing van de frontale en/of parietale botcentra worden gezien in 
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geval van aangedane corona, metopica of sagittaal naden. De 
betrokken botcentra zijn direct naast de synostotische sutuur 
gepositioneerd en het radiaire patroon van de botten is verstoord. De 
veranderde positie van de botcentra is een indirecte verwijzing naar 
het ontwikkelingsstadium tijdens welke de synostosis is ontstaan. De 
afstand tussen de twee botcentra correleert met het 
ontwikkelingsstadium waarin de botcentra tysiologisch op deze 
afstand van elkaar verwijderd liggen. Verdere groei tussen de 
botcentra wordt verhinderd door synostosis van de sutuur. Deze 
peri ode ligt rond de 16 weken gestatieduur voor de corona naad, het 
moment waarop de eerste aanzet van deze sutuur ontstaat. 
Bovenstaande resultaten kunnen worden vertaald naar een geschikte 
tijd om prenatale screening op craniosynostosis middels echografie te 
verrichten. Alhoewel de resultaten van deze morfologische studies 
enkele klinisch relevante gegevens hebben opgeleverd hebben zij niet 
geleid tot een nieuwe classificatie voor craniosynostosis. 
De genetische achtergrond van craniosynostosis leek een geschiktere 
basis voor een dergelijke classificatie. Een vereiste hiervoor is het in 
kaart brengen van de variaties in fenotype voor elke specifieke 
mutatie. In een pilot-studie werd een analyse verricht naar deze relatie 
bij onze patienten met craniosynostosis van wie de mutatie bekend 
was. Voor de meeste mutaties was het aantal patii:nten te klein om een 
zinvolle analyse toe te laten. Een patiente met de Ser35 1 Cys mutatie 
in FGFR2 werd door ons gepresenteerd gezien het zeer ernstige 
fenotype. Dit fenotype komt sterk overeen met dat van andere 
individueel beschreven patienten, passend bij een zeer sterke relatie 
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tussen genotype en fenotype voor de Ser35ICys mutatie (hoofdstuk 
IV.I). De Pro250Arg mutatie in FGFR3 werd nader geanalyseerd 
gezien de hoge incidentie en het vinden van additionele 
karakteristieken voor dit syndroom binnen onze populatie (hoofdstuk 
IV.2). Een klinisch relevante c1assificatie op basis van de genetica kan 
op dit moment nog niet ontwikkeld worden. Factoren die hiervoor 
bepalend zijn, zijn: a. het feit dat bij slechts de helft van de patienten 
met een syndromale craniosynostosis een mutatie wordt gevonden, b. 
het aantal patienten per individuele mutatie laag is en c. de soms zeer 
wisselende correlatie tussen genotype en fenotype. 
Door het ontdekken van de betrokken genen in craniosynostosis werd 
een nieuwe impuls gegeven aan het onderzoek naar de pathogenesis. 
De expressie en functie van deze genen tijdens de norrnale 
sutuurontwikkeling zijn voor het grootste deel onbekend, waardoor 
het extra moeilijk is om het mechanisme waarlangs synostosis wordt 
gelnduceerd te doorgronden. Om deze reden betrof ons eerste 
experimentele onderzoek een studie naar de norrnale ontwikkeling van 
de corona naad in de muis (hoofdstuk III.!). De nadruk lag hierbij op 
het optreden van geprogrammeerde celdood oftewel apoptosis, 
aangezien dit proces essentieel is tijdens norrnale embryogenesis en 
betrokken is in de pathogenesis van diverse congenitale afwijkingen. 
Tijdens de ontwikkeling van de corona naad treedt apoptosis op vanaf 
een specifieke periode, namelijk 16 dagen post conceptie, en weI over 
een zeer beperkt gebied, te weten de osteogene regio van de frontale 
en parietale botten waar deze elkaar naderen. 
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Om de diverse ontwikkelingsprocessen welke tot synostosis lei den te 
kunnen bestuderen werd een muis model ontwikkeld waarin de 
craniosynostosis gerelateerde FGFR2 mutatie werd nagebootst 
(hoofdstuk III.2). Hiertoe werd de corona naad van een muizenembryo 
blootgesteld aan een ectopische dosis fibroblast groeifactor (FGF) 2 of 
4 door middel van ex utero chirurgie. Aangetoond werd dat 
botvoorlopercellen binnen de sutuur voortijdig botdifferentiatie of 
apoptosis ondergingen gecombineerd met versterkte mineralisatie van 
het osteoid. Gebaseerd op de resultaten van deze en andere studies uit 
de literatuur wordt een poging gewaagd deze te vertalen naar de 
humane situatie. Het lijkt dat de cellen in de sutuur welke de 
gemuteerde receptor tot expressie brengen gedwongen worden tot 
voortijdige botdifferentiatie, ten koste van proliferatie. Hierdoor is de 
ossificatie versterkt terwijl de groei binnen de sutuur beperkt IS. 
Apoptosis is mogelijk betrokken bij de botdifferentiatie en 
mineralisatie aangezien er een gelijktijdige toename van apoptotische 
cellen binnen de behandelde muizensutuur werd gezien. De genetische 
mutaties in craniosynostosis lijken een verplaatsing van de balans 
tussen proliferatie en differentiatie - inc1usief apoptosis - binnen de 
sutuur te veroorzaken in de richting van de laatste. Aangezien de 
morfologische karakteristieken van een schedeldak in geval van een 
gelsoleerde en een syndromale craniosynostosis nagenoeg gelijk zijn, 
lijkt een vergelijkbare verstoring van de ontwikkelingsprocessen van 
de sutuur aan beide ten grondslag te liggen. 
Deze studie omvat aspecten van c1assificatie, morfologie, genetica en 
pathogenesis van craniosynostosis. Alhoewel relevante bevindingen 
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resulteerden van zowel klinische als fundamentele aard, blijven er 
meerdere aspecten onopgelost waarvoor aanbevelingen voor 
toekomstig onderzoek worden gedaan in hoofdstuk v. 
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